10
28 - 29 May 2020 | New York City
2nd Annual
IRDD Summit
A recent report from the Pharmaceutical Research and Manufacturers of America (PhRMA) found Americarsquos biopharmaceutical companies are developing about 130 new medicines for the millions of patients affected by respirator y diseases chronic obstructive pulmonary disease (COPD) cystic fibrosis pneumonia and asthma These medicines represent critical advancements in respiratory care and improving quality of l ife In addition to the drugs devices delivering those
products are being designed to improve the quality of l ife for an aging population children and those who tend not to comply to dosing regimens because they donrsquot know how to use the device The global respiratory care devices market is expected to exceed more than $24 billion by 2022 and could exceed $33 billion by 2023
The 2 nd Annual IRDD Summit 2020 will focus on the challenges of bringing respiratory products to market and innovative aerosol science
including modelling and toxicology Presentations will also feature key case studies on the latest trends in inhalation devices from inhaled insulin to gene therapy to overcome lung and pulmonary conditions such as COPD asthma and cystic fibrosisThe event highlights some of the innovators and innovations in the respiratory sector addresses the importance of end users in the device development process and presents recent advancements in improving patient adherence
B I O T E C H
P H A R M A
S U M M I T
On 28 amp 29 May 2020 New York (USA)
will host the 2 nd Annual IRDD Summit
2020 (Inhalation amp Respirator y Drug
Deliver y 2020 conference) This yearrsquos
event is designed for senior industry
experts that will showcase new trends
in aerosol science and the future
directions of inhalation drug delivery
research Further discussion focusses
on the regulatory pathways for
inhaled therapies and challenges of
bringing respiratory products to
market The agenda also features key
case studies on the latest trends in
inhalation devices from inhaled
insulin to gene therapy
W H O
S H O U L D
AT T E N D
bull Respiratory Drug Development
bull Generics amp Respiratory
bull Inhalation Drug Delivery Technologies
bull Device Development and Engineering
bull Respiratory Pharmacology
bull Medical Devices amp Injectors
bull Inhalation Device Development
bull Inhaled Formulation Science
bull Inhalation Product Development
bull Respiratory Regulations
bull Generics amp Respiratory
bull Respiratory Medicine
bull Inhalation Drug Delivery
bull E-Health
bull Inhaled Dosage Forms
bull Outsourcing
bull Process Development
Delegates typically include CEOs
VPs Drug developers Academics
and Researchers CROs Scientists
and Medical Doctors of
bull Novel technologies for pulmonary amp nasal delivery
bull Modern respiratory medicines
bull Innovative development of inhalation devices
bull Digital health combination products
bull Analytical tools for inhaled medicines
bull Regulatory updates in the global respiratory market
bull The challenges of developing inhalation devices
bull Alternative therapeutic fields
bull Innovation in nebulised therapy
bull Triple inhaler therapy in COPD
bull Routes to controll ing aerosol response
bull Characterizing aerosol dynamics
bull Model val idation
bull Regulatory pathways for inhaled therapies
K E Y P R A C T I C A L
L E A R N I N G P O I N T S
SIMON MOORE
Global Lead of Inhalation Science and Engineering at Covance
SVEN STEGEMANN
Professor of Patient Centric Drug Design And Manufacturing at The Graz University of Technology Austria
TONYA WINDERS
President and Chief Executive Officerof Allergy amp Asthma Network
WAYLAND RUSHING
Director Scientific Affairs at Eurofins Biopharma Product Testing
MARKMILTON-EDWARDS
Head of Product amp Health Solutions - Digital Health at Teva Pharmaceuticals
JOumlRG SCHIEWE
Head Of Global Cmc Experts at Boehringer Ingelheim Pharma Gmbh amp Co Kg
JUSTIN KALAFAT
Scientific Business Development Manager at Acg
MARCO LAACKMANN
Director Inhalation Technology at Harro Houmlfliger
MASAHIROSAKAGAMI
Professor Of Pharma-ceutics at Virginia Commonwealth University School of Pharmacy
MICHAEL CASTAGNA
Chief Executive Officer at MannkindCorporation
NATHALIEHEUZEacute-VOURCH
Research Professor at Inserm Research Centre For Respiratory Diseases
PETER ROBBINS
Professor Of Physiolo-gy at The Universityof Oxford
AERNOUT VAN HAARST
Director Scientific Affairs at CELERION
ARKADIUSZ KUCZAJ
Manager Aerosol Research and Dosime-try at Philip Morris International Research and Development
DIANA FERNANDES
Inhaled Biopharmaceutical Development Scientist at Hovione
FAKHRUL AHSAN
Professor at the Texas Tech University Health Sciences Center (Ttuhsc)
JEFFRY WEERS
Chief Technical Officer at Respira Therapeutics Inc
JAN DE BACKER
Ceo at Fluidda
FRANCESCA BUTTINI
Associate Professorat University of Parma Italy
DINO FARINA
Founder And Ceoat Proveris Scientific
S P E A K E R SMARTIN WING-KING
Director of Project Management at Quotient Sciences
TONYA WINDERS
President and Chief Executive Officerof Allergy amp Asthma Network
Wednesday Night Kick-Off
Pre-Event Registration amp Welcome Cocktail Reception
27052020 | 1900 - 2100
S C I E N T I F I C
A G E N D A
DAY 1
1300 Business Lunch
1400 Increasing the drug load in capsule based DPI drug delivery systemsBy Sven Stegemann - Professor of patient centric drug design and manufacturing at the Graz University of Technology Austria
Research in carrier based interactive powder mixtures
Considerations for powder-capsule optimization
Case studies
Approaches in particle engineering
1200 Administration of high dose antibiotic DPI formulationdevice combination for a cystic fibrosis patient-centric productBy Francesca Buttini - Associate Professor at University of Parma Italy
There is a need of novel powders and devices for better managing the lung administration of high dose antibiotics
A prototype capsule-based device was loaded with the entire powder dose and a gradual emission was obtained by performing 3-6 successive inhalation acts through the device
A novel particle engineering approach to construct antibiotic powder will be presented The tobramycin powder microparticles produced by spray drying using a minimal amount of sodium stearate exhibit a very small aerodynamic diameter low density and favourable shape for aerosolization
1230 Musings on High Dose Powder DeliveryBy Jeffry Weers - PhD Chief Technical Officer at Respira Therapeutics Inc
Tolerability of high powder doses
Why do we need these excipients anyway
Increasing packing density of fine spray-dried particles
1430 Formulation Development Challenges and Pitfalls When Developing Dry Powder InhalersBy Martin Wing-King - Director of Project Management at Quotient Sciences
1130 Formulation and Spray Drying Process Development of Inhaled BiopharmaceuticalsBy Diana Fernandes - Inhaled Biopharmaceutical Development Scientist at Hovione
Inhaled Biopharmaceuticals Current Outlook
Dry Powder Formulations for Biopharmaceutical Delivery Overview of Drying Technologies
Spray Dried Formulations for Biopharmaceutical Delivery
- The ldquoWhyrdquo- The ldquoChallenge
- The ldquoHowrdquo- Path Forward
Registration and Morning Coffee0800
0820 Opening of the 2nd Annual IRDD Summit 2020
0900 Speed Networking
1030 Morning Coffee amp Networking Break
Thursday May 28 2020
0830 Science base and challenges of therapeutic equivalence of respiratory productsBy Joumlrg Schiewe - Head of Global CMC Experts at Boehringer Ingelheim Pharma GmbH amp Co KG
What are the regulatory requirements for bioequivalence to bring respiratory products to the market Why are the requirements of US FDA so different to that of the European Medicines Agency
Scientific basis for bioequivalence and therapeutic equivalence Literature examples and case studies
Conclusion
0930 The biological barriers to consider for the development of inhaled biotherapeuticsBy Nathalie Heuzeacute-Vourch - Research Professor at INSERM Research Centre for Respiratory Diseases
Understanding the particularity of biotherapeutics inhalation
Passage of inhaled biotherapeutics from the airways into the systemic circulation
Biological barriers (mucus macrophages) that must be considered for the development of inhaled biotherapeutics
THE CHALLENGES OF DEVELOPING INHALATION DRUGS
1100 Accurate dosimetry predictions for evolving liquid aerosol deliveryBy Arkadiusz Kuczaj - PhD Manager Aerosol Research and Dosimetry at Philip Morris International Research and Development
Aerosol evolution as challenge in accurate dosimetry predictions
AeroSolved developed as computational fluid dynamics (CFD) package for complex aerosol simulations
Linking aerosol dosimetry with physiologically based pharmacokinetic (PBPK) modeling
Aerosol dosimetry requires joint experimental and computational efforts
1000 Early Phase Clinical Trials for Inhaled Drugs - Challenges and OpportunitiesBy Aernout van Haarst - PhD Director Scientific Affairs at Celerion
INHALATION FORMULATION SOLUTIONS amp TECHNOLOGY
Over 100+ delegates
representing global
pharmaceutical
organisations leading
biotech companies and
internationally renowned
academic institutions wil l
be joining the Inhalation
amp Respirator y Drug
Deliver y 2020
Over 20+ presentations
and case studies focused
on the key issues in
inhalation and
respiratory drug deliveryREGULATORY PATHWAYS FOR INHALED THERAPIES
1630 Get it right first time Inhaler technology and manufacturingBy Marco Laackmann - Director Inhalation Technology at Harro Houmlfliger
Criticality in up-scaling of DPI filling and manufacturing and the influence of powder dosing technologies on drug product performance
Options to improve machine capabilities based on powder characteristics and mechanical treatment to make cohesive powder free flowing for powder feeding and metering processes
Powder properties and fill weight accuracy for various dosing systems
1530 Speaking Sponsorship Available - Have your talk here
1600 Afternoon Coffee amp Networking Break
1800 Closing Remarks amp End of the First day
2000 The IRDD Summit 2020 Gala Dinner
1700 TBA (Innovative new testing platform - INVIDA - In Vitro Inhaled Drug Analysis)By Dino Farina - Founder and CEO at Proveris Scientific
NOVEL TECHNOLOGIES FOR PULMONARY amp NASAL DELIVERY
1500 Paving the way towards respiratory medicine using Functional Respiratory Imaging and AIBy Jan De Backer - PhD CEO at FLUIDDA
Efficient personalized medicine requires getting a handle on the heterogeneity of the patientrsquos disease AND the heterogeneity of the treatment and subsequently making the optimal match Imaging in combination with AI is increasingly used in clinical trials to understand the efficacy and heterogeneity of the novel treatments Low dose HRCT scans are readily available in clinical practice and can be used as a basis for advanced digital processing Hence all the ingredients for personalize medicine are there As such the respiratory field is expected to experience major change in the coming years This talk will discuss how this might all unfold
DAY 1
1730 Panel discussion Asthma inhalers what next for the drug delivery techWith speakers of both days
NEW APPROACHES TO INHALATION PRODUCT DEVELOPMENT AND PRODUCTION
1100 TBABy Wayland Rushing - Director Scientific Affairs at Eurofins BioPharma Product Testing
1500 Development of an Integrated Digital Health Product (DigihalerTM)By Mark Milton-Edwards - Head of Product amp Health Solutions - Digital Health at Teva Pharmaceuticals
1400 TBA (Development and commercialization of inhaled therapeutic products)By Michael Castagna - Chief Executive Officer at MannKind Corporation
1600 Use of 3d printing Computational fluid dynamics and customised engineering in inhalation pre-clinical developmentBy Simon Moore - Global Lead of Inhalation Science and Engineering at Covance
Learning Objectives
Designs that been assessed using computational fluid dynamics and ex vivo evaluation
Improving animal welfare and study conduct and integrity
Applying novel 3d scanning and 3d printer
DAY 2
1130 Speaking Sponsorship Available - Have your talk here
1430 Speaking Sponsorship Available - Have your talk here
1300 Business Lunch
1530 Afternoon Coffee amp Networking Break
1630 Chairmans closing remarks amp End of the IRDD Summit 2020
1200 Panel DiscussionFuture directions in inhalation and respiratory drug delivery research
Friday May 29 2020
Registration and Welcome Coffee0800
0820 IRDD 2020 Chairmans Opening Address
NEW APPROACHES TO TREATING RESPIRATORY DISEASES
NEW ANALYTICAL INSIGHTS INTO DRY POWDER FORMULATIONS FOR INHALATION
0830 TBABy Masahiro Sakagami - Professor of Pharmaceutics at Virginia Commonwealth University Schoolof Pharmacy
0900 Shared Decision Making to Improve Adherence in Severe AsthmaBy Tonya Winders - President and Chief Executive Officer at Allergy amp Asthma Network
Define Severe Asthma in accord with GINA guidelines
Utilize an online interactive shared decision making tool with severe asthma patients
Outline the benefits of SDM to improve adherence
Recognize four phenotypes of severe asthma
1000 Optimising surrogate outcome measures for respiratory trialsBy Peter Robbins - Professor of Physiology at the University of Oxford
The pharmaceutical industry should engage directly in optimising surrogate outcome measures for clinical trials Medical device companies do not have the same economic incentive associated with success
Inhomogeneity in lung function is an attractive target for developing a surrogate outcome measure that is more sensitive to early disease and to therapeutic intervention than those associated with airway calibre
The current measure of inhomogeneity the lung clearance index has many failings that limit its attractive-ness as a surrogate outcome measure These failings are both conceptual and methodological
1030 Morning Coffee amp Networking Break
0930 Inhalation therapy for pulmonary arterial hypertension a pulmonary vascular diseaseBy Fakhrul Ahsan - University Distinguished Professor in the Department of Pharmaceutical Sciences at the Texas Tech University Health Sciences Center (TTUHSC)
Plain drug versus controlled released formulation
Enhanced patient compliance
Reduced systemic side effects effects and reduced frequency of administration
All Prices displayed include VAT The VAT amount will be displayed after the payment process and shown on your invoice
Name
Position
Title
Name
Position
Title
PACKAGE NAME
Address
VAT No
Company
Signature
City
Date
Postcode
Phone
Gala Dinner
This booking is invalid without signature
Please send the signed form to this contact
Diogo Lino RibeiroProject Director Europe | Porto Office
EM diogoribeiroepmgrouporg
PH +351 915 239 640
R E G I S T R A T I O N
Team Discounts 3 Delegates
10
4 Delegates
15
5+ Delegates
20
Academic Med NPO Package
Industry Package
Premium Package
Super Early BirdUntil Jan10
$1100
$1795
$3650
Early BirdUntil Feb 14
$1350
$1995
$3800
Discounted TicketUntil Apr 25
$1500
$2250
$4150
Normal TicketAfter Apr 25
$1995
$2500
$4495
The 2nd Annual IRDD Summit is an exclusive limited seat event Early bird tickets are non-refundable and subject to availability
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
PREMIUM INDUSTRY PACKAGEIndividual Registration
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
BASIC INDUSTRY PACKAGEIndividual Registration
1-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
ONE-DAY INDUSTRY PASSIndividual Registration
By sending this form I confirm that I have read and accepted the terms and conditions detailed below
ConfirmationWe will confirm your participation after receiving the signed registration form the delegate will receive the invoice within 24h of sending the signed form The hotel details will be sent 2 or 3 weeks before the start of the conferenceCancellationsCancellations made one month prior to the start of the conference will be refunded less 50 administration charge Refunds will be made after the conference Cancellations made within one month of the conference start date will receive no refund Substitutes are accepted up to 3 days before the conference Any cancellation will be accepted latest one month before the event and should be informed in written form
Force MajeureWhile every reasonable effort will be made to adhere to the advertised package EPM Group reserves the right to change event dates sites or location omit event features or merge the event with another event as it deems necessary without penalty and in such situations no refunds part refunds or alternative offers shall be made (including but not limited to any force majeure occurence) and provided that the event is not postponed to a later date nor is it merged with another event the client shall receive a credit note for the amount that the client has paid to such permanently canceled event No refunds part refunds or alternative offers shall be madeCopyrightAll Intellectual Property rights in all materials produced or distributed by EPM Group in connection with this event are expressly reserved and any unauthorized duplication publication or distribution is prohibited
SILVER SPONSORSHIP
Opportunity to give a speech at the beginning of the conference[up to 40min]8m2 exhibition space with LCD Monitor for Video PresentationsFULL page Ad in conference programCompany Banner displayed at all the Sessions including Gala DinnerLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 5 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 5 delegates registered
Speaking slot [up to 40min]6m2 exhibition space with LCD Monitor for Video Presentationsfrac12 page Ad in conference programCompany Banner displayed at the reception desk amp Coffee breaksLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 4 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 4 delegates registered
GOLD SPONSORSHIP $18000(VAT INC) $14500(VAT INC)
SPEAKER SPONSORSHIP
Speaking slot [up to 40min]6m2 exhibition spacefrac14 page Ad in conference programCompany Banner displayed at the reception deskLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 3 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 3 delegates registered
Speaking slot [up to 40min]3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 2 delegates FREE-Admission (25 discount for extra ticket)
BRONZE SPONSORSHIP $10000(VAT INC) $6700(VAT INC)
EXHIBITION PACKAGE
Speaking slot [up to 40min]Logo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
KEYNOTE SPEECH PACKAGE $4500(VAT INC) $4500(VAT INC)
Click bellow to register as a sponsor
S P O N S O R S H I P P A C K A G E S
-dd mm yyyy
-
Yes No
A recent report from the Pharmaceutical Research and Manufacturers of America (PhRMA) found Americarsquos biopharmaceutical companies are developing about 130 new medicines for the millions of patients affected by respirator y diseases chronic obstructive pulmonary disease (COPD) cystic fibrosis pneumonia and asthma These medicines represent critical advancements in respiratory care and improving quality of l ife In addition to the drugs devices delivering those
products are being designed to improve the quality of l ife for an aging population children and those who tend not to comply to dosing regimens because they donrsquot know how to use the device The global respiratory care devices market is expected to exceed more than $24 billion by 2022 and could exceed $33 billion by 2023
The 2 nd Annual IRDD Summit 2020 will focus on the challenges of bringing respiratory products to market and innovative aerosol science
including modelling and toxicology Presentations will also feature key case studies on the latest trends in inhalation devices from inhaled insulin to gene therapy to overcome lung and pulmonary conditions such as COPD asthma and cystic fibrosisThe event highlights some of the innovators and innovations in the respiratory sector addresses the importance of end users in the device development process and presents recent advancements in improving patient adherence
B I O T E C H
P H A R M A
S U M M I T
On 28 amp 29 May 2020 New York (USA)
will host the 2 nd Annual IRDD Summit
2020 (Inhalation amp Respirator y Drug
Deliver y 2020 conference) This yearrsquos
event is designed for senior industry
experts that will showcase new trends
in aerosol science and the future
directions of inhalation drug delivery
research Further discussion focusses
on the regulatory pathways for
inhaled therapies and challenges of
bringing respiratory products to
market The agenda also features key
case studies on the latest trends in
inhalation devices from inhaled
insulin to gene therapy
W H O
S H O U L D
AT T E N D
bull Respiratory Drug Development
bull Generics amp Respiratory
bull Inhalation Drug Delivery Technologies
bull Device Development and Engineering
bull Respiratory Pharmacology
bull Medical Devices amp Injectors
bull Inhalation Device Development
bull Inhaled Formulation Science
bull Inhalation Product Development
bull Respiratory Regulations
bull Generics amp Respiratory
bull Respiratory Medicine
bull Inhalation Drug Delivery
bull E-Health
bull Inhaled Dosage Forms
bull Outsourcing
bull Process Development
Delegates typically include CEOs
VPs Drug developers Academics
and Researchers CROs Scientists
and Medical Doctors of
bull Novel technologies for pulmonary amp nasal delivery
bull Modern respiratory medicines
bull Innovative development of inhalation devices
bull Digital health combination products
bull Analytical tools for inhaled medicines
bull Regulatory updates in the global respiratory market
bull The challenges of developing inhalation devices
bull Alternative therapeutic fields
bull Innovation in nebulised therapy
bull Triple inhaler therapy in COPD
bull Routes to controll ing aerosol response
bull Characterizing aerosol dynamics
bull Model val idation
bull Regulatory pathways for inhaled therapies
K E Y P R A C T I C A L
L E A R N I N G P O I N T S
SIMON MOORE
Global Lead of Inhalation Science and Engineering at Covance
SVEN STEGEMANN
Professor of Patient Centric Drug Design And Manufacturing at The Graz University of Technology Austria
TONYA WINDERS
President and Chief Executive Officerof Allergy amp Asthma Network
WAYLAND RUSHING
Director Scientific Affairs at Eurofins Biopharma Product Testing
MARKMILTON-EDWARDS
Head of Product amp Health Solutions - Digital Health at Teva Pharmaceuticals
JOumlRG SCHIEWE
Head Of Global Cmc Experts at Boehringer Ingelheim Pharma Gmbh amp Co Kg
JUSTIN KALAFAT
Scientific Business Development Manager at Acg
MARCO LAACKMANN
Director Inhalation Technology at Harro Houmlfliger
MASAHIROSAKAGAMI
Professor Of Pharma-ceutics at Virginia Commonwealth University School of Pharmacy
MICHAEL CASTAGNA
Chief Executive Officer at MannkindCorporation
NATHALIEHEUZEacute-VOURCH
Research Professor at Inserm Research Centre For Respiratory Diseases
PETER ROBBINS
Professor Of Physiolo-gy at The Universityof Oxford
AERNOUT VAN HAARST
Director Scientific Affairs at CELERION
ARKADIUSZ KUCZAJ
Manager Aerosol Research and Dosime-try at Philip Morris International Research and Development
DIANA FERNANDES
Inhaled Biopharmaceutical Development Scientist at Hovione
FAKHRUL AHSAN
Professor at the Texas Tech University Health Sciences Center (Ttuhsc)
JEFFRY WEERS
Chief Technical Officer at Respira Therapeutics Inc
JAN DE BACKER
Ceo at Fluidda
FRANCESCA BUTTINI
Associate Professorat University of Parma Italy
DINO FARINA
Founder And Ceoat Proveris Scientific
S P E A K E R SMARTIN WING-KING
Director of Project Management at Quotient Sciences
TONYA WINDERS
President and Chief Executive Officerof Allergy amp Asthma Network
Wednesday Night Kick-Off
Pre-Event Registration amp Welcome Cocktail Reception
27052020 | 1900 - 2100
S C I E N T I F I C
A G E N D A
DAY 1
1300 Business Lunch
1400 Increasing the drug load in capsule based DPI drug delivery systemsBy Sven Stegemann - Professor of patient centric drug design and manufacturing at the Graz University of Technology Austria
Research in carrier based interactive powder mixtures
Considerations for powder-capsule optimization
Case studies
Approaches in particle engineering
1200 Administration of high dose antibiotic DPI formulationdevice combination for a cystic fibrosis patient-centric productBy Francesca Buttini - Associate Professor at University of Parma Italy
There is a need of novel powders and devices for better managing the lung administration of high dose antibiotics
A prototype capsule-based device was loaded with the entire powder dose and a gradual emission was obtained by performing 3-6 successive inhalation acts through the device
A novel particle engineering approach to construct antibiotic powder will be presented The tobramycin powder microparticles produced by spray drying using a minimal amount of sodium stearate exhibit a very small aerodynamic diameter low density and favourable shape for aerosolization
1230 Musings on High Dose Powder DeliveryBy Jeffry Weers - PhD Chief Technical Officer at Respira Therapeutics Inc
Tolerability of high powder doses
Why do we need these excipients anyway
Increasing packing density of fine spray-dried particles
1430 Formulation Development Challenges and Pitfalls When Developing Dry Powder InhalersBy Martin Wing-King - Director of Project Management at Quotient Sciences
1130 Formulation and Spray Drying Process Development of Inhaled BiopharmaceuticalsBy Diana Fernandes - Inhaled Biopharmaceutical Development Scientist at Hovione
Inhaled Biopharmaceuticals Current Outlook
Dry Powder Formulations for Biopharmaceutical Delivery Overview of Drying Technologies
Spray Dried Formulations for Biopharmaceutical Delivery
- The ldquoWhyrdquo- The ldquoChallenge
- The ldquoHowrdquo- Path Forward
Registration and Morning Coffee0800
0820 Opening of the 2nd Annual IRDD Summit 2020
0900 Speed Networking
1030 Morning Coffee amp Networking Break
Thursday May 28 2020
0830 Science base and challenges of therapeutic equivalence of respiratory productsBy Joumlrg Schiewe - Head of Global CMC Experts at Boehringer Ingelheim Pharma GmbH amp Co KG
What are the regulatory requirements for bioequivalence to bring respiratory products to the market Why are the requirements of US FDA so different to that of the European Medicines Agency
Scientific basis for bioequivalence and therapeutic equivalence Literature examples and case studies
Conclusion
0930 The biological barriers to consider for the development of inhaled biotherapeuticsBy Nathalie Heuzeacute-Vourch - Research Professor at INSERM Research Centre for Respiratory Diseases
Understanding the particularity of biotherapeutics inhalation
Passage of inhaled biotherapeutics from the airways into the systemic circulation
Biological barriers (mucus macrophages) that must be considered for the development of inhaled biotherapeutics
THE CHALLENGES OF DEVELOPING INHALATION DRUGS
1100 Accurate dosimetry predictions for evolving liquid aerosol deliveryBy Arkadiusz Kuczaj - PhD Manager Aerosol Research and Dosimetry at Philip Morris International Research and Development
Aerosol evolution as challenge in accurate dosimetry predictions
AeroSolved developed as computational fluid dynamics (CFD) package for complex aerosol simulations
Linking aerosol dosimetry with physiologically based pharmacokinetic (PBPK) modeling
Aerosol dosimetry requires joint experimental and computational efforts
1000 Early Phase Clinical Trials for Inhaled Drugs - Challenges and OpportunitiesBy Aernout van Haarst - PhD Director Scientific Affairs at Celerion
INHALATION FORMULATION SOLUTIONS amp TECHNOLOGY
Over 100+ delegates
representing global
pharmaceutical
organisations leading
biotech companies and
internationally renowned
academic institutions wil l
be joining the Inhalation
amp Respirator y Drug
Deliver y 2020
Over 20+ presentations
and case studies focused
on the key issues in
inhalation and
respiratory drug deliveryREGULATORY PATHWAYS FOR INHALED THERAPIES
1630 Get it right first time Inhaler technology and manufacturingBy Marco Laackmann - Director Inhalation Technology at Harro Houmlfliger
Criticality in up-scaling of DPI filling and manufacturing and the influence of powder dosing technologies on drug product performance
Options to improve machine capabilities based on powder characteristics and mechanical treatment to make cohesive powder free flowing for powder feeding and metering processes
Powder properties and fill weight accuracy for various dosing systems
1530 Speaking Sponsorship Available - Have your talk here
1600 Afternoon Coffee amp Networking Break
1800 Closing Remarks amp End of the First day
2000 The IRDD Summit 2020 Gala Dinner
1700 TBA (Innovative new testing platform - INVIDA - In Vitro Inhaled Drug Analysis)By Dino Farina - Founder and CEO at Proveris Scientific
NOVEL TECHNOLOGIES FOR PULMONARY amp NASAL DELIVERY
1500 Paving the way towards respiratory medicine using Functional Respiratory Imaging and AIBy Jan De Backer - PhD CEO at FLUIDDA
Efficient personalized medicine requires getting a handle on the heterogeneity of the patientrsquos disease AND the heterogeneity of the treatment and subsequently making the optimal match Imaging in combination with AI is increasingly used in clinical trials to understand the efficacy and heterogeneity of the novel treatments Low dose HRCT scans are readily available in clinical practice and can be used as a basis for advanced digital processing Hence all the ingredients for personalize medicine are there As such the respiratory field is expected to experience major change in the coming years This talk will discuss how this might all unfold
DAY 1
1730 Panel discussion Asthma inhalers what next for the drug delivery techWith speakers of both days
NEW APPROACHES TO INHALATION PRODUCT DEVELOPMENT AND PRODUCTION
1100 TBABy Wayland Rushing - Director Scientific Affairs at Eurofins BioPharma Product Testing
1500 Development of an Integrated Digital Health Product (DigihalerTM)By Mark Milton-Edwards - Head of Product amp Health Solutions - Digital Health at Teva Pharmaceuticals
1400 TBA (Development and commercialization of inhaled therapeutic products)By Michael Castagna - Chief Executive Officer at MannKind Corporation
1600 Use of 3d printing Computational fluid dynamics and customised engineering in inhalation pre-clinical developmentBy Simon Moore - Global Lead of Inhalation Science and Engineering at Covance
Learning Objectives
Designs that been assessed using computational fluid dynamics and ex vivo evaluation
Improving animal welfare and study conduct and integrity
Applying novel 3d scanning and 3d printer
DAY 2
1130 Speaking Sponsorship Available - Have your talk here
1430 Speaking Sponsorship Available - Have your talk here
1300 Business Lunch
1530 Afternoon Coffee amp Networking Break
1630 Chairmans closing remarks amp End of the IRDD Summit 2020
1200 Panel DiscussionFuture directions in inhalation and respiratory drug delivery research
Friday May 29 2020
Registration and Welcome Coffee0800
0820 IRDD 2020 Chairmans Opening Address
NEW APPROACHES TO TREATING RESPIRATORY DISEASES
NEW ANALYTICAL INSIGHTS INTO DRY POWDER FORMULATIONS FOR INHALATION
0830 TBABy Masahiro Sakagami - Professor of Pharmaceutics at Virginia Commonwealth University Schoolof Pharmacy
0900 Shared Decision Making to Improve Adherence in Severe AsthmaBy Tonya Winders - President and Chief Executive Officer at Allergy amp Asthma Network
Define Severe Asthma in accord with GINA guidelines
Utilize an online interactive shared decision making tool with severe asthma patients
Outline the benefits of SDM to improve adherence
Recognize four phenotypes of severe asthma
1000 Optimising surrogate outcome measures for respiratory trialsBy Peter Robbins - Professor of Physiology at the University of Oxford
The pharmaceutical industry should engage directly in optimising surrogate outcome measures for clinical trials Medical device companies do not have the same economic incentive associated with success
Inhomogeneity in lung function is an attractive target for developing a surrogate outcome measure that is more sensitive to early disease and to therapeutic intervention than those associated with airway calibre
The current measure of inhomogeneity the lung clearance index has many failings that limit its attractive-ness as a surrogate outcome measure These failings are both conceptual and methodological
1030 Morning Coffee amp Networking Break
0930 Inhalation therapy for pulmonary arterial hypertension a pulmonary vascular diseaseBy Fakhrul Ahsan - University Distinguished Professor in the Department of Pharmaceutical Sciences at the Texas Tech University Health Sciences Center (TTUHSC)
Plain drug versus controlled released formulation
Enhanced patient compliance
Reduced systemic side effects effects and reduced frequency of administration
All Prices displayed include VAT The VAT amount will be displayed after the payment process and shown on your invoice
Name
Position
Title
Name
Position
Title
PACKAGE NAME
Address
VAT No
Company
Signature
City
Date
Postcode
Phone
Gala Dinner
This booking is invalid without signature
Please send the signed form to this contact
Diogo Lino RibeiroProject Director Europe | Porto Office
EM diogoribeiroepmgrouporg
PH +351 915 239 640
R E G I S T R A T I O N
Team Discounts 3 Delegates
10
4 Delegates
15
5+ Delegates
20
Academic Med NPO Package
Industry Package
Premium Package
Super Early BirdUntil Jan10
$1100
$1795
$3650
Early BirdUntil Feb 14
$1350
$1995
$3800
Discounted TicketUntil Apr 25
$1500
$2250
$4150
Normal TicketAfter Apr 25
$1995
$2500
$4495
The 2nd Annual IRDD Summit is an exclusive limited seat event Early bird tickets are non-refundable and subject to availability
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
PREMIUM INDUSTRY PACKAGEIndividual Registration
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
BASIC INDUSTRY PACKAGEIndividual Registration
1-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
ONE-DAY INDUSTRY PASSIndividual Registration
By sending this form I confirm that I have read and accepted the terms and conditions detailed below
ConfirmationWe will confirm your participation after receiving the signed registration form the delegate will receive the invoice within 24h of sending the signed form The hotel details will be sent 2 or 3 weeks before the start of the conferenceCancellationsCancellations made one month prior to the start of the conference will be refunded less 50 administration charge Refunds will be made after the conference Cancellations made within one month of the conference start date will receive no refund Substitutes are accepted up to 3 days before the conference Any cancellation will be accepted latest one month before the event and should be informed in written form
Force MajeureWhile every reasonable effort will be made to adhere to the advertised package EPM Group reserves the right to change event dates sites or location omit event features or merge the event with another event as it deems necessary without penalty and in such situations no refunds part refunds or alternative offers shall be made (including but not limited to any force majeure occurence) and provided that the event is not postponed to a later date nor is it merged with another event the client shall receive a credit note for the amount that the client has paid to such permanently canceled event No refunds part refunds or alternative offers shall be madeCopyrightAll Intellectual Property rights in all materials produced or distributed by EPM Group in connection with this event are expressly reserved and any unauthorized duplication publication or distribution is prohibited
SILVER SPONSORSHIP
Opportunity to give a speech at the beginning of the conference[up to 40min]8m2 exhibition space with LCD Monitor for Video PresentationsFULL page Ad in conference programCompany Banner displayed at all the Sessions including Gala DinnerLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 5 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 5 delegates registered
Speaking slot [up to 40min]6m2 exhibition space with LCD Monitor for Video Presentationsfrac12 page Ad in conference programCompany Banner displayed at the reception desk amp Coffee breaksLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 4 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 4 delegates registered
GOLD SPONSORSHIP $18000(VAT INC) $14500(VAT INC)
SPEAKER SPONSORSHIP
Speaking slot [up to 40min]6m2 exhibition spacefrac14 page Ad in conference programCompany Banner displayed at the reception deskLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 3 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 3 delegates registered
Speaking slot [up to 40min]3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 2 delegates FREE-Admission (25 discount for extra ticket)
BRONZE SPONSORSHIP $10000(VAT INC) $6700(VAT INC)
EXHIBITION PACKAGE
Speaking slot [up to 40min]Logo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
KEYNOTE SPEECH PACKAGE $4500(VAT INC) $4500(VAT INC)
Click bellow to register as a sponsor
S P O N S O R S H I P P A C K A G E S
-dd mm yyyy
-
Yes No
W H O
S H O U L D
AT T E N D
bull Respiratory Drug Development
bull Generics amp Respiratory
bull Inhalation Drug Delivery Technologies
bull Device Development and Engineering
bull Respiratory Pharmacology
bull Medical Devices amp Injectors
bull Inhalation Device Development
bull Inhaled Formulation Science
bull Inhalation Product Development
bull Respiratory Regulations
bull Generics amp Respiratory
bull Respiratory Medicine
bull Inhalation Drug Delivery
bull E-Health
bull Inhaled Dosage Forms
bull Outsourcing
bull Process Development
Delegates typically include CEOs
VPs Drug developers Academics
and Researchers CROs Scientists
and Medical Doctors of
bull Novel technologies for pulmonary amp nasal delivery
bull Modern respiratory medicines
bull Innovative development of inhalation devices
bull Digital health combination products
bull Analytical tools for inhaled medicines
bull Regulatory updates in the global respiratory market
bull The challenges of developing inhalation devices
bull Alternative therapeutic fields
bull Innovation in nebulised therapy
bull Triple inhaler therapy in COPD
bull Routes to controll ing aerosol response
bull Characterizing aerosol dynamics
bull Model val idation
bull Regulatory pathways for inhaled therapies
K E Y P R A C T I C A L
L E A R N I N G P O I N T S
SIMON MOORE
Global Lead of Inhalation Science and Engineering at Covance
SVEN STEGEMANN
Professor of Patient Centric Drug Design And Manufacturing at The Graz University of Technology Austria
TONYA WINDERS
President and Chief Executive Officerof Allergy amp Asthma Network
WAYLAND RUSHING
Director Scientific Affairs at Eurofins Biopharma Product Testing
MARKMILTON-EDWARDS
Head of Product amp Health Solutions - Digital Health at Teva Pharmaceuticals
JOumlRG SCHIEWE
Head Of Global Cmc Experts at Boehringer Ingelheim Pharma Gmbh amp Co Kg
JUSTIN KALAFAT
Scientific Business Development Manager at Acg
MARCO LAACKMANN
Director Inhalation Technology at Harro Houmlfliger
MASAHIROSAKAGAMI
Professor Of Pharma-ceutics at Virginia Commonwealth University School of Pharmacy
MICHAEL CASTAGNA
Chief Executive Officer at MannkindCorporation
NATHALIEHEUZEacute-VOURCH
Research Professor at Inserm Research Centre For Respiratory Diseases
PETER ROBBINS
Professor Of Physiolo-gy at The Universityof Oxford
AERNOUT VAN HAARST
Director Scientific Affairs at CELERION
ARKADIUSZ KUCZAJ
Manager Aerosol Research and Dosime-try at Philip Morris International Research and Development
DIANA FERNANDES
Inhaled Biopharmaceutical Development Scientist at Hovione
FAKHRUL AHSAN
Professor at the Texas Tech University Health Sciences Center (Ttuhsc)
JEFFRY WEERS
Chief Technical Officer at Respira Therapeutics Inc
JAN DE BACKER
Ceo at Fluidda
FRANCESCA BUTTINI
Associate Professorat University of Parma Italy
DINO FARINA
Founder And Ceoat Proveris Scientific
S P E A K E R SMARTIN WING-KING
Director of Project Management at Quotient Sciences
TONYA WINDERS
President and Chief Executive Officerof Allergy amp Asthma Network
Wednesday Night Kick-Off
Pre-Event Registration amp Welcome Cocktail Reception
27052020 | 1900 - 2100
S C I E N T I F I C
A G E N D A
DAY 1
1300 Business Lunch
1400 Increasing the drug load in capsule based DPI drug delivery systemsBy Sven Stegemann - Professor of patient centric drug design and manufacturing at the Graz University of Technology Austria
Research in carrier based interactive powder mixtures
Considerations for powder-capsule optimization
Case studies
Approaches in particle engineering
1200 Administration of high dose antibiotic DPI formulationdevice combination for a cystic fibrosis patient-centric productBy Francesca Buttini - Associate Professor at University of Parma Italy
There is a need of novel powders and devices for better managing the lung administration of high dose antibiotics
A prototype capsule-based device was loaded with the entire powder dose and a gradual emission was obtained by performing 3-6 successive inhalation acts through the device
A novel particle engineering approach to construct antibiotic powder will be presented The tobramycin powder microparticles produced by spray drying using a minimal amount of sodium stearate exhibit a very small aerodynamic diameter low density and favourable shape for aerosolization
1230 Musings on High Dose Powder DeliveryBy Jeffry Weers - PhD Chief Technical Officer at Respira Therapeutics Inc
Tolerability of high powder doses
Why do we need these excipients anyway
Increasing packing density of fine spray-dried particles
1430 Formulation Development Challenges and Pitfalls When Developing Dry Powder InhalersBy Martin Wing-King - Director of Project Management at Quotient Sciences
1130 Formulation and Spray Drying Process Development of Inhaled BiopharmaceuticalsBy Diana Fernandes - Inhaled Biopharmaceutical Development Scientist at Hovione
Inhaled Biopharmaceuticals Current Outlook
Dry Powder Formulations for Biopharmaceutical Delivery Overview of Drying Technologies
Spray Dried Formulations for Biopharmaceutical Delivery
- The ldquoWhyrdquo- The ldquoChallenge
- The ldquoHowrdquo- Path Forward
Registration and Morning Coffee0800
0820 Opening of the 2nd Annual IRDD Summit 2020
0900 Speed Networking
1030 Morning Coffee amp Networking Break
Thursday May 28 2020
0830 Science base and challenges of therapeutic equivalence of respiratory productsBy Joumlrg Schiewe - Head of Global CMC Experts at Boehringer Ingelheim Pharma GmbH amp Co KG
What are the regulatory requirements for bioequivalence to bring respiratory products to the market Why are the requirements of US FDA so different to that of the European Medicines Agency
Scientific basis for bioequivalence and therapeutic equivalence Literature examples and case studies
Conclusion
0930 The biological barriers to consider for the development of inhaled biotherapeuticsBy Nathalie Heuzeacute-Vourch - Research Professor at INSERM Research Centre for Respiratory Diseases
Understanding the particularity of biotherapeutics inhalation
Passage of inhaled biotherapeutics from the airways into the systemic circulation
Biological barriers (mucus macrophages) that must be considered for the development of inhaled biotherapeutics
THE CHALLENGES OF DEVELOPING INHALATION DRUGS
1100 Accurate dosimetry predictions for evolving liquid aerosol deliveryBy Arkadiusz Kuczaj - PhD Manager Aerosol Research and Dosimetry at Philip Morris International Research and Development
Aerosol evolution as challenge in accurate dosimetry predictions
AeroSolved developed as computational fluid dynamics (CFD) package for complex aerosol simulations
Linking aerosol dosimetry with physiologically based pharmacokinetic (PBPK) modeling
Aerosol dosimetry requires joint experimental and computational efforts
1000 Early Phase Clinical Trials for Inhaled Drugs - Challenges and OpportunitiesBy Aernout van Haarst - PhD Director Scientific Affairs at Celerion
INHALATION FORMULATION SOLUTIONS amp TECHNOLOGY
Over 100+ delegates
representing global
pharmaceutical
organisations leading
biotech companies and
internationally renowned
academic institutions wil l
be joining the Inhalation
amp Respirator y Drug
Deliver y 2020
Over 20+ presentations
and case studies focused
on the key issues in
inhalation and
respiratory drug deliveryREGULATORY PATHWAYS FOR INHALED THERAPIES
1630 Get it right first time Inhaler technology and manufacturingBy Marco Laackmann - Director Inhalation Technology at Harro Houmlfliger
Criticality in up-scaling of DPI filling and manufacturing and the influence of powder dosing technologies on drug product performance
Options to improve machine capabilities based on powder characteristics and mechanical treatment to make cohesive powder free flowing for powder feeding and metering processes
Powder properties and fill weight accuracy for various dosing systems
1530 Speaking Sponsorship Available - Have your talk here
1600 Afternoon Coffee amp Networking Break
1800 Closing Remarks amp End of the First day
2000 The IRDD Summit 2020 Gala Dinner
1700 TBA (Innovative new testing platform - INVIDA - In Vitro Inhaled Drug Analysis)By Dino Farina - Founder and CEO at Proveris Scientific
NOVEL TECHNOLOGIES FOR PULMONARY amp NASAL DELIVERY
1500 Paving the way towards respiratory medicine using Functional Respiratory Imaging and AIBy Jan De Backer - PhD CEO at FLUIDDA
Efficient personalized medicine requires getting a handle on the heterogeneity of the patientrsquos disease AND the heterogeneity of the treatment and subsequently making the optimal match Imaging in combination with AI is increasingly used in clinical trials to understand the efficacy and heterogeneity of the novel treatments Low dose HRCT scans are readily available in clinical practice and can be used as a basis for advanced digital processing Hence all the ingredients for personalize medicine are there As such the respiratory field is expected to experience major change in the coming years This talk will discuss how this might all unfold
DAY 1
1730 Panel discussion Asthma inhalers what next for the drug delivery techWith speakers of both days
NEW APPROACHES TO INHALATION PRODUCT DEVELOPMENT AND PRODUCTION
1100 TBABy Wayland Rushing - Director Scientific Affairs at Eurofins BioPharma Product Testing
1500 Development of an Integrated Digital Health Product (DigihalerTM)By Mark Milton-Edwards - Head of Product amp Health Solutions - Digital Health at Teva Pharmaceuticals
1400 TBA (Development and commercialization of inhaled therapeutic products)By Michael Castagna - Chief Executive Officer at MannKind Corporation
1600 Use of 3d printing Computational fluid dynamics and customised engineering in inhalation pre-clinical developmentBy Simon Moore - Global Lead of Inhalation Science and Engineering at Covance
Learning Objectives
Designs that been assessed using computational fluid dynamics and ex vivo evaluation
Improving animal welfare and study conduct and integrity
Applying novel 3d scanning and 3d printer
DAY 2
1130 Speaking Sponsorship Available - Have your talk here
1430 Speaking Sponsorship Available - Have your talk here
1300 Business Lunch
1530 Afternoon Coffee amp Networking Break
1630 Chairmans closing remarks amp End of the IRDD Summit 2020
1200 Panel DiscussionFuture directions in inhalation and respiratory drug delivery research
Friday May 29 2020
Registration and Welcome Coffee0800
0820 IRDD 2020 Chairmans Opening Address
NEW APPROACHES TO TREATING RESPIRATORY DISEASES
NEW ANALYTICAL INSIGHTS INTO DRY POWDER FORMULATIONS FOR INHALATION
0830 TBABy Masahiro Sakagami - Professor of Pharmaceutics at Virginia Commonwealth University Schoolof Pharmacy
0900 Shared Decision Making to Improve Adherence in Severe AsthmaBy Tonya Winders - President and Chief Executive Officer at Allergy amp Asthma Network
Define Severe Asthma in accord with GINA guidelines
Utilize an online interactive shared decision making tool with severe asthma patients
Outline the benefits of SDM to improve adherence
Recognize four phenotypes of severe asthma
1000 Optimising surrogate outcome measures for respiratory trialsBy Peter Robbins - Professor of Physiology at the University of Oxford
The pharmaceutical industry should engage directly in optimising surrogate outcome measures for clinical trials Medical device companies do not have the same economic incentive associated with success
Inhomogeneity in lung function is an attractive target for developing a surrogate outcome measure that is more sensitive to early disease and to therapeutic intervention than those associated with airway calibre
The current measure of inhomogeneity the lung clearance index has many failings that limit its attractive-ness as a surrogate outcome measure These failings are both conceptual and methodological
1030 Morning Coffee amp Networking Break
0930 Inhalation therapy for pulmonary arterial hypertension a pulmonary vascular diseaseBy Fakhrul Ahsan - University Distinguished Professor in the Department of Pharmaceutical Sciences at the Texas Tech University Health Sciences Center (TTUHSC)
Plain drug versus controlled released formulation
Enhanced patient compliance
Reduced systemic side effects effects and reduced frequency of administration
All Prices displayed include VAT The VAT amount will be displayed after the payment process and shown on your invoice
Name
Position
Title
Name
Position
Title
PACKAGE NAME
Address
VAT No
Company
Signature
City
Date
Postcode
Phone
Gala Dinner
This booking is invalid without signature
Please send the signed form to this contact
Diogo Lino RibeiroProject Director Europe | Porto Office
EM diogoribeiroepmgrouporg
PH +351 915 239 640
R E G I S T R A T I O N
Team Discounts 3 Delegates
10
4 Delegates
15
5+ Delegates
20
Academic Med NPO Package
Industry Package
Premium Package
Super Early BirdUntil Jan10
$1100
$1795
$3650
Early BirdUntil Feb 14
$1350
$1995
$3800
Discounted TicketUntil Apr 25
$1500
$2250
$4150
Normal TicketAfter Apr 25
$1995
$2500
$4495
The 2nd Annual IRDD Summit is an exclusive limited seat event Early bird tickets are non-refundable and subject to availability
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
PREMIUM INDUSTRY PACKAGEIndividual Registration
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
BASIC INDUSTRY PACKAGEIndividual Registration
1-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
ONE-DAY INDUSTRY PASSIndividual Registration
By sending this form I confirm that I have read and accepted the terms and conditions detailed below
ConfirmationWe will confirm your participation after receiving the signed registration form the delegate will receive the invoice within 24h of sending the signed form The hotel details will be sent 2 or 3 weeks before the start of the conferenceCancellationsCancellations made one month prior to the start of the conference will be refunded less 50 administration charge Refunds will be made after the conference Cancellations made within one month of the conference start date will receive no refund Substitutes are accepted up to 3 days before the conference Any cancellation will be accepted latest one month before the event and should be informed in written form
Force MajeureWhile every reasonable effort will be made to adhere to the advertised package EPM Group reserves the right to change event dates sites or location omit event features or merge the event with another event as it deems necessary without penalty and in such situations no refunds part refunds or alternative offers shall be made (including but not limited to any force majeure occurence) and provided that the event is not postponed to a later date nor is it merged with another event the client shall receive a credit note for the amount that the client has paid to such permanently canceled event No refunds part refunds or alternative offers shall be madeCopyrightAll Intellectual Property rights in all materials produced or distributed by EPM Group in connection with this event are expressly reserved and any unauthorized duplication publication or distribution is prohibited
SILVER SPONSORSHIP
Opportunity to give a speech at the beginning of the conference[up to 40min]8m2 exhibition space with LCD Monitor for Video PresentationsFULL page Ad in conference programCompany Banner displayed at all the Sessions including Gala DinnerLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 5 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 5 delegates registered
Speaking slot [up to 40min]6m2 exhibition space with LCD Monitor for Video Presentationsfrac12 page Ad in conference programCompany Banner displayed at the reception desk amp Coffee breaksLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 4 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 4 delegates registered
GOLD SPONSORSHIP $18000(VAT INC) $14500(VAT INC)
SPEAKER SPONSORSHIP
Speaking slot [up to 40min]6m2 exhibition spacefrac14 page Ad in conference programCompany Banner displayed at the reception deskLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 3 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 3 delegates registered
Speaking slot [up to 40min]3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 2 delegates FREE-Admission (25 discount for extra ticket)
BRONZE SPONSORSHIP $10000(VAT INC) $6700(VAT INC)
EXHIBITION PACKAGE
Speaking slot [up to 40min]Logo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
KEYNOTE SPEECH PACKAGE $4500(VAT INC) $4500(VAT INC)
Click bellow to register as a sponsor
S P O N S O R S H I P P A C K A G E S
-dd mm yyyy
-
Yes No
SIMON MOORE
Global Lead of Inhalation Science and Engineering at Covance
SVEN STEGEMANN
Professor of Patient Centric Drug Design And Manufacturing at The Graz University of Technology Austria
TONYA WINDERS
President and Chief Executive Officerof Allergy amp Asthma Network
WAYLAND RUSHING
Director Scientific Affairs at Eurofins Biopharma Product Testing
MARKMILTON-EDWARDS
Head of Product amp Health Solutions - Digital Health at Teva Pharmaceuticals
JOumlRG SCHIEWE
Head Of Global Cmc Experts at Boehringer Ingelheim Pharma Gmbh amp Co Kg
JUSTIN KALAFAT
Scientific Business Development Manager at Acg
MARCO LAACKMANN
Director Inhalation Technology at Harro Houmlfliger
MASAHIROSAKAGAMI
Professor Of Pharma-ceutics at Virginia Commonwealth University School of Pharmacy
MICHAEL CASTAGNA
Chief Executive Officer at MannkindCorporation
NATHALIEHEUZEacute-VOURCH
Research Professor at Inserm Research Centre For Respiratory Diseases
PETER ROBBINS
Professor Of Physiolo-gy at The Universityof Oxford
AERNOUT VAN HAARST
Director Scientific Affairs at CELERION
ARKADIUSZ KUCZAJ
Manager Aerosol Research and Dosime-try at Philip Morris International Research and Development
DIANA FERNANDES
Inhaled Biopharmaceutical Development Scientist at Hovione
FAKHRUL AHSAN
Professor at the Texas Tech University Health Sciences Center (Ttuhsc)
JEFFRY WEERS
Chief Technical Officer at Respira Therapeutics Inc
JAN DE BACKER
Ceo at Fluidda
FRANCESCA BUTTINI
Associate Professorat University of Parma Italy
DINO FARINA
Founder And Ceoat Proveris Scientific
S P E A K E R SMARTIN WING-KING
Director of Project Management at Quotient Sciences
TONYA WINDERS
President and Chief Executive Officerof Allergy amp Asthma Network
Wednesday Night Kick-Off
Pre-Event Registration amp Welcome Cocktail Reception
27052020 | 1900 - 2100
S C I E N T I F I C
A G E N D A
DAY 1
1300 Business Lunch
1400 Increasing the drug load in capsule based DPI drug delivery systemsBy Sven Stegemann - Professor of patient centric drug design and manufacturing at the Graz University of Technology Austria
Research in carrier based interactive powder mixtures
Considerations for powder-capsule optimization
Case studies
Approaches in particle engineering
1200 Administration of high dose antibiotic DPI formulationdevice combination for a cystic fibrosis patient-centric productBy Francesca Buttini - Associate Professor at University of Parma Italy
There is a need of novel powders and devices for better managing the lung administration of high dose antibiotics
A prototype capsule-based device was loaded with the entire powder dose and a gradual emission was obtained by performing 3-6 successive inhalation acts through the device
A novel particle engineering approach to construct antibiotic powder will be presented The tobramycin powder microparticles produced by spray drying using a minimal amount of sodium stearate exhibit a very small aerodynamic diameter low density and favourable shape for aerosolization
1230 Musings on High Dose Powder DeliveryBy Jeffry Weers - PhD Chief Technical Officer at Respira Therapeutics Inc
Tolerability of high powder doses
Why do we need these excipients anyway
Increasing packing density of fine spray-dried particles
1430 Formulation Development Challenges and Pitfalls When Developing Dry Powder InhalersBy Martin Wing-King - Director of Project Management at Quotient Sciences
1130 Formulation and Spray Drying Process Development of Inhaled BiopharmaceuticalsBy Diana Fernandes - Inhaled Biopharmaceutical Development Scientist at Hovione
Inhaled Biopharmaceuticals Current Outlook
Dry Powder Formulations for Biopharmaceutical Delivery Overview of Drying Technologies
Spray Dried Formulations for Biopharmaceutical Delivery
- The ldquoWhyrdquo- The ldquoChallenge
- The ldquoHowrdquo- Path Forward
Registration and Morning Coffee0800
0820 Opening of the 2nd Annual IRDD Summit 2020
0900 Speed Networking
1030 Morning Coffee amp Networking Break
Thursday May 28 2020
0830 Science base and challenges of therapeutic equivalence of respiratory productsBy Joumlrg Schiewe - Head of Global CMC Experts at Boehringer Ingelheim Pharma GmbH amp Co KG
What are the regulatory requirements for bioequivalence to bring respiratory products to the market Why are the requirements of US FDA so different to that of the European Medicines Agency
Scientific basis for bioequivalence and therapeutic equivalence Literature examples and case studies
Conclusion
0930 The biological barriers to consider for the development of inhaled biotherapeuticsBy Nathalie Heuzeacute-Vourch - Research Professor at INSERM Research Centre for Respiratory Diseases
Understanding the particularity of biotherapeutics inhalation
Passage of inhaled biotherapeutics from the airways into the systemic circulation
Biological barriers (mucus macrophages) that must be considered for the development of inhaled biotherapeutics
THE CHALLENGES OF DEVELOPING INHALATION DRUGS
1100 Accurate dosimetry predictions for evolving liquid aerosol deliveryBy Arkadiusz Kuczaj - PhD Manager Aerosol Research and Dosimetry at Philip Morris International Research and Development
Aerosol evolution as challenge in accurate dosimetry predictions
AeroSolved developed as computational fluid dynamics (CFD) package for complex aerosol simulations
Linking aerosol dosimetry with physiologically based pharmacokinetic (PBPK) modeling
Aerosol dosimetry requires joint experimental and computational efforts
1000 Early Phase Clinical Trials for Inhaled Drugs - Challenges and OpportunitiesBy Aernout van Haarst - PhD Director Scientific Affairs at Celerion
INHALATION FORMULATION SOLUTIONS amp TECHNOLOGY
Over 100+ delegates
representing global
pharmaceutical
organisations leading
biotech companies and
internationally renowned
academic institutions wil l
be joining the Inhalation
amp Respirator y Drug
Deliver y 2020
Over 20+ presentations
and case studies focused
on the key issues in
inhalation and
respiratory drug deliveryREGULATORY PATHWAYS FOR INHALED THERAPIES
1630 Get it right first time Inhaler technology and manufacturingBy Marco Laackmann - Director Inhalation Technology at Harro Houmlfliger
Criticality in up-scaling of DPI filling and manufacturing and the influence of powder dosing technologies on drug product performance
Options to improve machine capabilities based on powder characteristics and mechanical treatment to make cohesive powder free flowing for powder feeding and metering processes
Powder properties and fill weight accuracy for various dosing systems
1530 Speaking Sponsorship Available - Have your talk here
1600 Afternoon Coffee amp Networking Break
1800 Closing Remarks amp End of the First day
2000 The IRDD Summit 2020 Gala Dinner
1700 TBA (Innovative new testing platform - INVIDA - In Vitro Inhaled Drug Analysis)By Dino Farina - Founder and CEO at Proveris Scientific
NOVEL TECHNOLOGIES FOR PULMONARY amp NASAL DELIVERY
1500 Paving the way towards respiratory medicine using Functional Respiratory Imaging and AIBy Jan De Backer - PhD CEO at FLUIDDA
Efficient personalized medicine requires getting a handle on the heterogeneity of the patientrsquos disease AND the heterogeneity of the treatment and subsequently making the optimal match Imaging in combination with AI is increasingly used in clinical trials to understand the efficacy and heterogeneity of the novel treatments Low dose HRCT scans are readily available in clinical practice and can be used as a basis for advanced digital processing Hence all the ingredients for personalize medicine are there As such the respiratory field is expected to experience major change in the coming years This talk will discuss how this might all unfold
DAY 1
1730 Panel discussion Asthma inhalers what next for the drug delivery techWith speakers of both days
NEW APPROACHES TO INHALATION PRODUCT DEVELOPMENT AND PRODUCTION
1100 TBABy Wayland Rushing - Director Scientific Affairs at Eurofins BioPharma Product Testing
1500 Development of an Integrated Digital Health Product (DigihalerTM)By Mark Milton-Edwards - Head of Product amp Health Solutions - Digital Health at Teva Pharmaceuticals
1400 TBA (Development and commercialization of inhaled therapeutic products)By Michael Castagna - Chief Executive Officer at MannKind Corporation
1600 Use of 3d printing Computational fluid dynamics and customised engineering in inhalation pre-clinical developmentBy Simon Moore - Global Lead of Inhalation Science and Engineering at Covance
Learning Objectives
Designs that been assessed using computational fluid dynamics and ex vivo evaluation
Improving animal welfare and study conduct and integrity
Applying novel 3d scanning and 3d printer
DAY 2
1130 Speaking Sponsorship Available - Have your talk here
1430 Speaking Sponsorship Available - Have your talk here
1300 Business Lunch
1530 Afternoon Coffee amp Networking Break
1630 Chairmans closing remarks amp End of the IRDD Summit 2020
1200 Panel DiscussionFuture directions in inhalation and respiratory drug delivery research
Friday May 29 2020
Registration and Welcome Coffee0800
0820 IRDD 2020 Chairmans Opening Address
NEW APPROACHES TO TREATING RESPIRATORY DISEASES
NEW ANALYTICAL INSIGHTS INTO DRY POWDER FORMULATIONS FOR INHALATION
0830 TBABy Masahiro Sakagami - Professor of Pharmaceutics at Virginia Commonwealth University Schoolof Pharmacy
0900 Shared Decision Making to Improve Adherence in Severe AsthmaBy Tonya Winders - President and Chief Executive Officer at Allergy amp Asthma Network
Define Severe Asthma in accord with GINA guidelines
Utilize an online interactive shared decision making tool with severe asthma patients
Outline the benefits of SDM to improve adherence
Recognize four phenotypes of severe asthma
1000 Optimising surrogate outcome measures for respiratory trialsBy Peter Robbins - Professor of Physiology at the University of Oxford
The pharmaceutical industry should engage directly in optimising surrogate outcome measures for clinical trials Medical device companies do not have the same economic incentive associated with success
Inhomogeneity in lung function is an attractive target for developing a surrogate outcome measure that is more sensitive to early disease and to therapeutic intervention than those associated with airway calibre
The current measure of inhomogeneity the lung clearance index has many failings that limit its attractive-ness as a surrogate outcome measure These failings are both conceptual and methodological
1030 Morning Coffee amp Networking Break
0930 Inhalation therapy for pulmonary arterial hypertension a pulmonary vascular diseaseBy Fakhrul Ahsan - University Distinguished Professor in the Department of Pharmaceutical Sciences at the Texas Tech University Health Sciences Center (TTUHSC)
Plain drug versus controlled released formulation
Enhanced patient compliance
Reduced systemic side effects effects and reduced frequency of administration
All Prices displayed include VAT The VAT amount will be displayed after the payment process and shown on your invoice
Name
Position
Title
Name
Position
Title
PACKAGE NAME
Address
VAT No
Company
Signature
City
Date
Postcode
Phone
Gala Dinner
This booking is invalid without signature
Please send the signed form to this contact
Diogo Lino RibeiroProject Director Europe | Porto Office
EM diogoribeiroepmgrouporg
PH +351 915 239 640
R E G I S T R A T I O N
Team Discounts 3 Delegates
10
4 Delegates
15
5+ Delegates
20
Academic Med NPO Package
Industry Package
Premium Package
Super Early BirdUntil Jan10
$1100
$1795
$3650
Early BirdUntil Feb 14
$1350
$1995
$3800
Discounted TicketUntil Apr 25
$1500
$2250
$4150
Normal TicketAfter Apr 25
$1995
$2500
$4495
The 2nd Annual IRDD Summit is an exclusive limited seat event Early bird tickets are non-refundable and subject to availability
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
PREMIUM INDUSTRY PACKAGEIndividual Registration
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
BASIC INDUSTRY PACKAGEIndividual Registration
1-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
ONE-DAY INDUSTRY PASSIndividual Registration
By sending this form I confirm that I have read and accepted the terms and conditions detailed below
ConfirmationWe will confirm your participation after receiving the signed registration form the delegate will receive the invoice within 24h of sending the signed form The hotel details will be sent 2 or 3 weeks before the start of the conferenceCancellationsCancellations made one month prior to the start of the conference will be refunded less 50 administration charge Refunds will be made after the conference Cancellations made within one month of the conference start date will receive no refund Substitutes are accepted up to 3 days before the conference Any cancellation will be accepted latest one month before the event and should be informed in written form
Force MajeureWhile every reasonable effort will be made to adhere to the advertised package EPM Group reserves the right to change event dates sites or location omit event features or merge the event with another event as it deems necessary without penalty and in such situations no refunds part refunds or alternative offers shall be made (including but not limited to any force majeure occurence) and provided that the event is not postponed to a later date nor is it merged with another event the client shall receive a credit note for the amount that the client has paid to such permanently canceled event No refunds part refunds or alternative offers shall be madeCopyrightAll Intellectual Property rights in all materials produced or distributed by EPM Group in connection with this event are expressly reserved and any unauthorized duplication publication or distribution is prohibited
SILVER SPONSORSHIP
Opportunity to give a speech at the beginning of the conference[up to 40min]8m2 exhibition space with LCD Monitor for Video PresentationsFULL page Ad in conference programCompany Banner displayed at all the Sessions including Gala DinnerLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 5 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 5 delegates registered
Speaking slot [up to 40min]6m2 exhibition space with LCD Monitor for Video Presentationsfrac12 page Ad in conference programCompany Banner displayed at the reception desk amp Coffee breaksLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 4 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 4 delegates registered
GOLD SPONSORSHIP $18000(VAT INC) $14500(VAT INC)
SPEAKER SPONSORSHIP
Speaking slot [up to 40min]6m2 exhibition spacefrac14 page Ad in conference programCompany Banner displayed at the reception deskLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 3 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 3 delegates registered
Speaking slot [up to 40min]3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 2 delegates FREE-Admission (25 discount for extra ticket)
BRONZE SPONSORSHIP $10000(VAT INC) $6700(VAT INC)
EXHIBITION PACKAGE
Speaking slot [up to 40min]Logo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
KEYNOTE SPEECH PACKAGE $4500(VAT INC) $4500(VAT INC)
Click bellow to register as a sponsor
S P O N S O R S H I P P A C K A G E S
-dd mm yyyy
-
Yes No
Wednesday Night Kick-Off
Pre-Event Registration amp Welcome Cocktail Reception
27052020 | 1900 - 2100
S C I E N T I F I C
A G E N D A
DAY 1
1300 Business Lunch
1400 Increasing the drug load in capsule based DPI drug delivery systemsBy Sven Stegemann - Professor of patient centric drug design and manufacturing at the Graz University of Technology Austria
Research in carrier based interactive powder mixtures
Considerations for powder-capsule optimization
Case studies
Approaches in particle engineering
1200 Administration of high dose antibiotic DPI formulationdevice combination for a cystic fibrosis patient-centric productBy Francesca Buttini - Associate Professor at University of Parma Italy
There is a need of novel powders and devices for better managing the lung administration of high dose antibiotics
A prototype capsule-based device was loaded with the entire powder dose and a gradual emission was obtained by performing 3-6 successive inhalation acts through the device
A novel particle engineering approach to construct antibiotic powder will be presented The tobramycin powder microparticles produced by spray drying using a minimal amount of sodium stearate exhibit a very small aerodynamic diameter low density and favourable shape for aerosolization
1230 Musings on High Dose Powder DeliveryBy Jeffry Weers - PhD Chief Technical Officer at Respira Therapeutics Inc
Tolerability of high powder doses
Why do we need these excipients anyway
Increasing packing density of fine spray-dried particles
1430 Formulation Development Challenges and Pitfalls When Developing Dry Powder InhalersBy Martin Wing-King - Director of Project Management at Quotient Sciences
1130 Formulation and Spray Drying Process Development of Inhaled BiopharmaceuticalsBy Diana Fernandes - Inhaled Biopharmaceutical Development Scientist at Hovione
Inhaled Biopharmaceuticals Current Outlook
Dry Powder Formulations for Biopharmaceutical Delivery Overview of Drying Technologies
Spray Dried Formulations for Biopharmaceutical Delivery
- The ldquoWhyrdquo- The ldquoChallenge
- The ldquoHowrdquo- Path Forward
Registration and Morning Coffee0800
0820 Opening of the 2nd Annual IRDD Summit 2020
0900 Speed Networking
1030 Morning Coffee amp Networking Break
Thursday May 28 2020
0830 Science base and challenges of therapeutic equivalence of respiratory productsBy Joumlrg Schiewe - Head of Global CMC Experts at Boehringer Ingelheim Pharma GmbH amp Co KG
What are the regulatory requirements for bioequivalence to bring respiratory products to the market Why are the requirements of US FDA so different to that of the European Medicines Agency
Scientific basis for bioequivalence and therapeutic equivalence Literature examples and case studies
Conclusion
0930 The biological barriers to consider for the development of inhaled biotherapeuticsBy Nathalie Heuzeacute-Vourch - Research Professor at INSERM Research Centre for Respiratory Diseases
Understanding the particularity of biotherapeutics inhalation
Passage of inhaled biotherapeutics from the airways into the systemic circulation
Biological barriers (mucus macrophages) that must be considered for the development of inhaled biotherapeutics
THE CHALLENGES OF DEVELOPING INHALATION DRUGS
1100 Accurate dosimetry predictions for evolving liquid aerosol deliveryBy Arkadiusz Kuczaj - PhD Manager Aerosol Research and Dosimetry at Philip Morris International Research and Development
Aerosol evolution as challenge in accurate dosimetry predictions
AeroSolved developed as computational fluid dynamics (CFD) package for complex aerosol simulations
Linking aerosol dosimetry with physiologically based pharmacokinetic (PBPK) modeling
Aerosol dosimetry requires joint experimental and computational efforts
1000 Early Phase Clinical Trials for Inhaled Drugs - Challenges and OpportunitiesBy Aernout van Haarst - PhD Director Scientific Affairs at Celerion
INHALATION FORMULATION SOLUTIONS amp TECHNOLOGY
Over 100+ delegates
representing global
pharmaceutical
organisations leading
biotech companies and
internationally renowned
academic institutions wil l
be joining the Inhalation
amp Respirator y Drug
Deliver y 2020
Over 20+ presentations
and case studies focused
on the key issues in
inhalation and
respiratory drug deliveryREGULATORY PATHWAYS FOR INHALED THERAPIES
1630 Get it right first time Inhaler technology and manufacturingBy Marco Laackmann - Director Inhalation Technology at Harro Houmlfliger
Criticality in up-scaling of DPI filling and manufacturing and the influence of powder dosing technologies on drug product performance
Options to improve machine capabilities based on powder characteristics and mechanical treatment to make cohesive powder free flowing for powder feeding and metering processes
Powder properties and fill weight accuracy for various dosing systems
1530 Speaking Sponsorship Available - Have your talk here
1600 Afternoon Coffee amp Networking Break
1800 Closing Remarks amp End of the First day
2000 The IRDD Summit 2020 Gala Dinner
1700 TBA (Innovative new testing platform - INVIDA - In Vitro Inhaled Drug Analysis)By Dino Farina - Founder and CEO at Proveris Scientific
NOVEL TECHNOLOGIES FOR PULMONARY amp NASAL DELIVERY
1500 Paving the way towards respiratory medicine using Functional Respiratory Imaging and AIBy Jan De Backer - PhD CEO at FLUIDDA
Efficient personalized medicine requires getting a handle on the heterogeneity of the patientrsquos disease AND the heterogeneity of the treatment and subsequently making the optimal match Imaging in combination with AI is increasingly used in clinical trials to understand the efficacy and heterogeneity of the novel treatments Low dose HRCT scans are readily available in clinical practice and can be used as a basis for advanced digital processing Hence all the ingredients for personalize medicine are there As such the respiratory field is expected to experience major change in the coming years This talk will discuss how this might all unfold
DAY 1
1730 Panel discussion Asthma inhalers what next for the drug delivery techWith speakers of both days
NEW APPROACHES TO INHALATION PRODUCT DEVELOPMENT AND PRODUCTION
1100 TBABy Wayland Rushing - Director Scientific Affairs at Eurofins BioPharma Product Testing
1500 Development of an Integrated Digital Health Product (DigihalerTM)By Mark Milton-Edwards - Head of Product amp Health Solutions - Digital Health at Teva Pharmaceuticals
1400 TBA (Development and commercialization of inhaled therapeutic products)By Michael Castagna - Chief Executive Officer at MannKind Corporation
1600 Use of 3d printing Computational fluid dynamics and customised engineering in inhalation pre-clinical developmentBy Simon Moore - Global Lead of Inhalation Science and Engineering at Covance
Learning Objectives
Designs that been assessed using computational fluid dynamics and ex vivo evaluation
Improving animal welfare and study conduct and integrity
Applying novel 3d scanning and 3d printer
DAY 2
1130 Speaking Sponsorship Available - Have your talk here
1430 Speaking Sponsorship Available - Have your talk here
1300 Business Lunch
1530 Afternoon Coffee amp Networking Break
1630 Chairmans closing remarks amp End of the IRDD Summit 2020
1200 Panel DiscussionFuture directions in inhalation and respiratory drug delivery research
Friday May 29 2020
Registration and Welcome Coffee0800
0820 IRDD 2020 Chairmans Opening Address
NEW APPROACHES TO TREATING RESPIRATORY DISEASES
NEW ANALYTICAL INSIGHTS INTO DRY POWDER FORMULATIONS FOR INHALATION
0830 TBABy Masahiro Sakagami - Professor of Pharmaceutics at Virginia Commonwealth University Schoolof Pharmacy
0900 Shared Decision Making to Improve Adherence in Severe AsthmaBy Tonya Winders - President and Chief Executive Officer at Allergy amp Asthma Network
Define Severe Asthma in accord with GINA guidelines
Utilize an online interactive shared decision making tool with severe asthma patients
Outline the benefits of SDM to improve adherence
Recognize four phenotypes of severe asthma
1000 Optimising surrogate outcome measures for respiratory trialsBy Peter Robbins - Professor of Physiology at the University of Oxford
The pharmaceutical industry should engage directly in optimising surrogate outcome measures for clinical trials Medical device companies do not have the same economic incentive associated with success
Inhomogeneity in lung function is an attractive target for developing a surrogate outcome measure that is more sensitive to early disease and to therapeutic intervention than those associated with airway calibre
The current measure of inhomogeneity the lung clearance index has many failings that limit its attractive-ness as a surrogate outcome measure These failings are both conceptual and methodological
1030 Morning Coffee amp Networking Break
0930 Inhalation therapy for pulmonary arterial hypertension a pulmonary vascular diseaseBy Fakhrul Ahsan - University Distinguished Professor in the Department of Pharmaceutical Sciences at the Texas Tech University Health Sciences Center (TTUHSC)
Plain drug versus controlled released formulation
Enhanced patient compliance
Reduced systemic side effects effects and reduced frequency of administration
All Prices displayed include VAT The VAT amount will be displayed after the payment process and shown on your invoice
Name
Position
Title
Name
Position
Title
PACKAGE NAME
Address
VAT No
Company
Signature
City
Date
Postcode
Phone
Gala Dinner
This booking is invalid without signature
Please send the signed form to this contact
Diogo Lino RibeiroProject Director Europe | Porto Office
EM diogoribeiroepmgrouporg
PH +351 915 239 640
R E G I S T R A T I O N
Team Discounts 3 Delegates
10
4 Delegates
15
5+ Delegates
20
Academic Med NPO Package
Industry Package
Premium Package
Super Early BirdUntil Jan10
$1100
$1795
$3650
Early BirdUntil Feb 14
$1350
$1995
$3800
Discounted TicketUntil Apr 25
$1500
$2250
$4150
Normal TicketAfter Apr 25
$1995
$2500
$4495
The 2nd Annual IRDD Summit is an exclusive limited seat event Early bird tickets are non-refundable and subject to availability
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
PREMIUM INDUSTRY PACKAGEIndividual Registration
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
BASIC INDUSTRY PACKAGEIndividual Registration
1-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
ONE-DAY INDUSTRY PASSIndividual Registration
By sending this form I confirm that I have read and accepted the terms and conditions detailed below
ConfirmationWe will confirm your participation after receiving the signed registration form the delegate will receive the invoice within 24h of sending the signed form The hotel details will be sent 2 or 3 weeks before the start of the conferenceCancellationsCancellations made one month prior to the start of the conference will be refunded less 50 administration charge Refunds will be made after the conference Cancellations made within one month of the conference start date will receive no refund Substitutes are accepted up to 3 days before the conference Any cancellation will be accepted latest one month before the event and should be informed in written form
Force MajeureWhile every reasonable effort will be made to adhere to the advertised package EPM Group reserves the right to change event dates sites or location omit event features or merge the event with another event as it deems necessary without penalty and in such situations no refunds part refunds or alternative offers shall be made (including but not limited to any force majeure occurence) and provided that the event is not postponed to a later date nor is it merged with another event the client shall receive a credit note for the amount that the client has paid to such permanently canceled event No refunds part refunds or alternative offers shall be madeCopyrightAll Intellectual Property rights in all materials produced or distributed by EPM Group in connection with this event are expressly reserved and any unauthorized duplication publication or distribution is prohibited
SILVER SPONSORSHIP
Opportunity to give a speech at the beginning of the conference[up to 40min]8m2 exhibition space with LCD Monitor for Video PresentationsFULL page Ad in conference programCompany Banner displayed at all the Sessions including Gala DinnerLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 5 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 5 delegates registered
Speaking slot [up to 40min]6m2 exhibition space with LCD Monitor for Video Presentationsfrac12 page Ad in conference programCompany Banner displayed at the reception desk amp Coffee breaksLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 4 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 4 delegates registered
GOLD SPONSORSHIP $18000(VAT INC) $14500(VAT INC)
SPEAKER SPONSORSHIP
Speaking slot [up to 40min]6m2 exhibition spacefrac14 page Ad in conference programCompany Banner displayed at the reception deskLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 3 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 3 delegates registered
Speaking slot [up to 40min]3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 2 delegates FREE-Admission (25 discount for extra ticket)
BRONZE SPONSORSHIP $10000(VAT INC) $6700(VAT INC)
EXHIBITION PACKAGE
Speaking slot [up to 40min]Logo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
KEYNOTE SPEECH PACKAGE $4500(VAT INC) $4500(VAT INC)
Click bellow to register as a sponsor
S P O N S O R S H I P P A C K A G E S
-dd mm yyyy
-
Yes No
DAY 1
1300 Business Lunch
1400 Increasing the drug load in capsule based DPI drug delivery systemsBy Sven Stegemann - Professor of patient centric drug design and manufacturing at the Graz University of Technology Austria
Research in carrier based interactive powder mixtures
Considerations for powder-capsule optimization
Case studies
Approaches in particle engineering
1200 Administration of high dose antibiotic DPI formulationdevice combination for a cystic fibrosis patient-centric productBy Francesca Buttini - Associate Professor at University of Parma Italy
There is a need of novel powders and devices for better managing the lung administration of high dose antibiotics
A prototype capsule-based device was loaded with the entire powder dose and a gradual emission was obtained by performing 3-6 successive inhalation acts through the device
A novel particle engineering approach to construct antibiotic powder will be presented The tobramycin powder microparticles produced by spray drying using a minimal amount of sodium stearate exhibit a very small aerodynamic diameter low density and favourable shape for aerosolization
1230 Musings on High Dose Powder DeliveryBy Jeffry Weers - PhD Chief Technical Officer at Respira Therapeutics Inc
Tolerability of high powder doses
Why do we need these excipients anyway
Increasing packing density of fine spray-dried particles
1430 Formulation Development Challenges and Pitfalls When Developing Dry Powder InhalersBy Martin Wing-King - Director of Project Management at Quotient Sciences
1130 Formulation and Spray Drying Process Development of Inhaled BiopharmaceuticalsBy Diana Fernandes - Inhaled Biopharmaceutical Development Scientist at Hovione
Inhaled Biopharmaceuticals Current Outlook
Dry Powder Formulations for Biopharmaceutical Delivery Overview of Drying Technologies
Spray Dried Formulations for Biopharmaceutical Delivery
- The ldquoWhyrdquo- The ldquoChallenge
- The ldquoHowrdquo- Path Forward
Registration and Morning Coffee0800
0820 Opening of the 2nd Annual IRDD Summit 2020
0900 Speed Networking
1030 Morning Coffee amp Networking Break
Thursday May 28 2020
0830 Science base and challenges of therapeutic equivalence of respiratory productsBy Joumlrg Schiewe - Head of Global CMC Experts at Boehringer Ingelheim Pharma GmbH amp Co KG
What are the regulatory requirements for bioequivalence to bring respiratory products to the market Why are the requirements of US FDA so different to that of the European Medicines Agency
Scientific basis for bioequivalence and therapeutic equivalence Literature examples and case studies
Conclusion
0930 The biological barriers to consider for the development of inhaled biotherapeuticsBy Nathalie Heuzeacute-Vourch - Research Professor at INSERM Research Centre for Respiratory Diseases
Understanding the particularity of biotherapeutics inhalation
Passage of inhaled biotherapeutics from the airways into the systemic circulation
Biological barriers (mucus macrophages) that must be considered for the development of inhaled biotherapeutics
THE CHALLENGES OF DEVELOPING INHALATION DRUGS
1100 Accurate dosimetry predictions for evolving liquid aerosol deliveryBy Arkadiusz Kuczaj - PhD Manager Aerosol Research and Dosimetry at Philip Morris International Research and Development
Aerosol evolution as challenge in accurate dosimetry predictions
AeroSolved developed as computational fluid dynamics (CFD) package for complex aerosol simulations
Linking aerosol dosimetry with physiologically based pharmacokinetic (PBPK) modeling
Aerosol dosimetry requires joint experimental and computational efforts
1000 Early Phase Clinical Trials for Inhaled Drugs - Challenges and OpportunitiesBy Aernout van Haarst - PhD Director Scientific Affairs at Celerion
INHALATION FORMULATION SOLUTIONS amp TECHNOLOGY
Over 100+ delegates
representing global
pharmaceutical
organisations leading
biotech companies and
internationally renowned
academic institutions wil l
be joining the Inhalation
amp Respirator y Drug
Deliver y 2020
Over 20+ presentations
and case studies focused
on the key issues in
inhalation and
respiratory drug deliveryREGULATORY PATHWAYS FOR INHALED THERAPIES
1630 Get it right first time Inhaler technology and manufacturingBy Marco Laackmann - Director Inhalation Technology at Harro Houmlfliger
Criticality in up-scaling of DPI filling and manufacturing and the influence of powder dosing technologies on drug product performance
Options to improve machine capabilities based on powder characteristics and mechanical treatment to make cohesive powder free flowing for powder feeding and metering processes
Powder properties and fill weight accuracy for various dosing systems
1530 Speaking Sponsorship Available - Have your talk here
1600 Afternoon Coffee amp Networking Break
1800 Closing Remarks amp End of the First day
2000 The IRDD Summit 2020 Gala Dinner
1700 TBA (Innovative new testing platform - INVIDA - In Vitro Inhaled Drug Analysis)By Dino Farina - Founder and CEO at Proveris Scientific
NOVEL TECHNOLOGIES FOR PULMONARY amp NASAL DELIVERY
1500 Paving the way towards respiratory medicine using Functional Respiratory Imaging and AIBy Jan De Backer - PhD CEO at FLUIDDA
Efficient personalized medicine requires getting a handle on the heterogeneity of the patientrsquos disease AND the heterogeneity of the treatment and subsequently making the optimal match Imaging in combination with AI is increasingly used in clinical trials to understand the efficacy and heterogeneity of the novel treatments Low dose HRCT scans are readily available in clinical practice and can be used as a basis for advanced digital processing Hence all the ingredients for personalize medicine are there As such the respiratory field is expected to experience major change in the coming years This talk will discuss how this might all unfold
DAY 1
1730 Panel discussion Asthma inhalers what next for the drug delivery techWith speakers of both days
NEW APPROACHES TO INHALATION PRODUCT DEVELOPMENT AND PRODUCTION
1100 TBABy Wayland Rushing - Director Scientific Affairs at Eurofins BioPharma Product Testing
1500 Development of an Integrated Digital Health Product (DigihalerTM)By Mark Milton-Edwards - Head of Product amp Health Solutions - Digital Health at Teva Pharmaceuticals
1400 TBA (Development and commercialization of inhaled therapeutic products)By Michael Castagna - Chief Executive Officer at MannKind Corporation
1600 Use of 3d printing Computational fluid dynamics and customised engineering in inhalation pre-clinical developmentBy Simon Moore - Global Lead of Inhalation Science and Engineering at Covance
Learning Objectives
Designs that been assessed using computational fluid dynamics and ex vivo evaluation
Improving animal welfare and study conduct and integrity
Applying novel 3d scanning and 3d printer
DAY 2
1130 Speaking Sponsorship Available - Have your talk here
1430 Speaking Sponsorship Available - Have your talk here
1300 Business Lunch
1530 Afternoon Coffee amp Networking Break
1630 Chairmans closing remarks amp End of the IRDD Summit 2020
1200 Panel DiscussionFuture directions in inhalation and respiratory drug delivery research
Friday May 29 2020
Registration and Welcome Coffee0800
0820 IRDD 2020 Chairmans Opening Address
NEW APPROACHES TO TREATING RESPIRATORY DISEASES
NEW ANALYTICAL INSIGHTS INTO DRY POWDER FORMULATIONS FOR INHALATION
0830 TBABy Masahiro Sakagami - Professor of Pharmaceutics at Virginia Commonwealth University Schoolof Pharmacy
0900 Shared Decision Making to Improve Adherence in Severe AsthmaBy Tonya Winders - President and Chief Executive Officer at Allergy amp Asthma Network
Define Severe Asthma in accord with GINA guidelines
Utilize an online interactive shared decision making tool with severe asthma patients
Outline the benefits of SDM to improve adherence
Recognize four phenotypes of severe asthma
1000 Optimising surrogate outcome measures for respiratory trialsBy Peter Robbins - Professor of Physiology at the University of Oxford
The pharmaceutical industry should engage directly in optimising surrogate outcome measures for clinical trials Medical device companies do not have the same economic incentive associated with success
Inhomogeneity in lung function is an attractive target for developing a surrogate outcome measure that is more sensitive to early disease and to therapeutic intervention than those associated with airway calibre
The current measure of inhomogeneity the lung clearance index has many failings that limit its attractive-ness as a surrogate outcome measure These failings are both conceptual and methodological
1030 Morning Coffee amp Networking Break
0930 Inhalation therapy for pulmonary arterial hypertension a pulmonary vascular diseaseBy Fakhrul Ahsan - University Distinguished Professor in the Department of Pharmaceutical Sciences at the Texas Tech University Health Sciences Center (TTUHSC)
Plain drug versus controlled released formulation
Enhanced patient compliance
Reduced systemic side effects effects and reduced frequency of administration
All Prices displayed include VAT The VAT amount will be displayed after the payment process and shown on your invoice
Name
Position
Title
Name
Position
Title
PACKAGE NAME
Address
VAT No
Company
Signature
City
Date
Postcode
Phone
Gala Dinner
This booking is invalid without signature
Please send the signed form to this contact
Diogo Lino RibeiroProject Director Europe | Porto Office
EM diogoribeiroepmgrouporg
PH +351 915 239 640
R E G I S T R A T I O N
Team Discounts 3 Delegates
10
4 Delegates
15
5+ Delegates
20
Academic Med NPO Package
Industry Package
Premium Package
Super Early BirdUntil Jan10
$1100
$1795
$3650
Early BirdUntil Feb 14
$1350
$1995
$3800
Discounted TicketUntil Apr 25
$1500
$2250
$4150
Normal TicketAfter Apr 25
$1995
$2500
$4495
The 2nd Annual IRDD Summit is an exclusive limited seat event Early bird tickets are non-refundable and subject to availability
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
PREMIUM INDUSTRY PACKAGEIndividual Registration
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
BASIC INDUSTRY PACKAGEIndividual Registration
1-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
ONE-DAY INDUSTRY PASSIndividual Registration
By sending this form I confirm that I have read and accepted the terms and conditions detailed below
ConfirmationWe will confirm your participation after receiving the signed registration form the delegate will receive the invoice within 24h of sending the signed form The hotel details will be sent 2 or 3 weeks before the start of the conferenceCancellationsCancellations made one month prior to the start of the conference will be refunded less 50 administration charge Refunds will be made after the conference Cancellations made within one month of the conference start date will receive no refund Substitutes are accepted up to 3 days before the conference Any cancellation will be accepted latest one month before the event and should be informed in written form
Force MajeureWhile every reasonable effort will be made to adhere to the advertised package EPM Group reserves the right to change event dates sites or location omit event features or merge the event with another event as it deems necessary without penalty and in such situations no refunds part refunds or alternative offers shall be made (including but not limited to any force majeure occurence) and provided that the event is not postponed to a later date nor is it merged with another event the client shall receive a credit note for the amount that the client has paid to such permanently canceled event No refunds part refunds or alternative offers shall be madeCopyrightAll Intellectual Property rights in all materials produced or distributed by EPM Group in connection with this event are expressly reserved and any unauthorized duplication publication or distribution is prohibited
SILVER SPONSORSHIP
Opportunity to give a speech at the beginning of the conference[up to 40min]8m2 exhibition space with LCD Monitor for Video PresentationsFULL page Ad in conference programCompany Banner displayed at all the Sessions including Gala DinnerLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 5 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 5 delegates registered
Speaking slot [up to 40min]6m2 exhibition space with LCD Monitor for Video Presentationsfrac12 page Ad in conference programCompany Banner displayed at the reception desk amp Coffee breaksLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 4 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 4 delegates registered
GOLD SPONSORSHIP $18000(VAT INC) $14500(VAT INC)
SPEAKER SPONSORSHIP
Speaking slot [up to 40min]6m2 exhibition spacefrac14 page Ad in conference programCompany Banner displayed at the reception deskLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 3 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 3 delegates registered
Speaking slot [up to 40min]3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 2 delegates FREE-Admission (25 discount for extra ticket)
BRONZE SPONSORSHIP $10000(VAT INC) $6700(VAT INC)
EXHIBITION PACKAGE
Speaking slot [up to 40min]Logo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
KEYNOTE SPEECH PACKAGE $4500(VAT INC) $4500(VAT INC)
Click bellow to register as a sponsor
S P O N S O R S H I P P A C K A G E S
-dd mm yyyy
-
Yes No
Over 100+ delegates
representing global
pharmaceutical
organisations leading
biotech companies and
internationally renowned
academic institutions wil l
be joining the Inhalation
amp Respirator y Drug
Deliver y 2020
Over 20+ presentations
and case studies focused
on the key issues in
inhalation and
respiratory drug deliveryREGULATORY PATHWAYS FOR INHALED THERAPIES
1630 Get it right first time Inhaler technology and manufacturingBy Marco Laackmann - Director Inhalation Technology at Harro Houmlfliger
Criticality in up-scaling of DPI filling and manufacturing and the influence of powder dosing technologies on drug product performance
Options to improve machine capabilities based on powder characteristics and mechanical treatment to make cohesive powder free flowing for powder feeding and metering processes
Powder properties and fill weight accuracy for various dosing systems
1530 Speaking Sponsorship Available - Have your talk here
1600 Afternoon Coffee amp Networking Break
1800 Closing Remarks amp End of the First day
2000 The IRDD Summit 2020 Gala Dinner
1700 TBA (Innovative new testing platform - INVIDA - In Vitro Inhaled Drug Analysis)By Dino Farina - Founder and CEO at Proveris Scientific
NOVEL TECHNOLOGIES FOR PULMONARY amp NASAL DELIVERY
1500 Paving the way towards respiratory medicine using Functional Respiratory Imaging and AIBy Jan De Backer - PhD CEO at FLUIDDA
Efficient personalized medicine requires getting a handle on the heterogeneity of the patientrsquos disease AND the heterogeneity of the treatment and subsequently making the optimal match Imaging in combination with AI is increasingly used in clinical trials to understand the efficacy and heterogeneity of the novel treatments Low dose HRCT scans are readily available in clinical practice and can be used as a basis for advanced digital processing Hence all the ingredients for personalize medicine are there As such the respiratory field is expected to experience major change in the coming years This talk will discuss how this might all unfold
DAY 1
1730 Panel discussion Asthma inhalers what next for the drug delivery techWith speakers of both days
NEW APPROACHES TO INHALATION PRODUCT DEVELOPMENT AND PRODUCTION
1100 TBABy Wayland Rushing - Director Scientific Affairs at Eurofins BioPharma Product Testing
1500 Development of an Integrated Digital Health Product (DigihalerTM)By Mark Milton-Edwards - Head of Product amp Health Solutions - Digital Health at Teva Pharmaceuticals
1400 TBA (Development and commercialization of inhaled therapeutic products)By Michael Castagna - Chief Executive Officer at MannKind Corporation
1600 Use of 3d printing Computational fluid dynamics and customised engineering in inhalation pre-clinical developmentBy Simon Moore - Global Lead of Inhalation Science and Engineering at Covance
Learning Objectives
Designs that been assessed using computational fluid dynamics and ex vivo evaluation
Improving animal welfare and study conduct and integrity
Applying novel 3d scanning and 3d printer
DAY 2
1130 Speaking Sponsorship Available - Have your talk here
1430 Speaking Sponsorship Available - Have your talk here
1300 Business Lunch
1530 Afternoon Coffee amp Networking Break
1630 Chairmans closing remarks amp End of the IRDD Summit 2020
1200 Panel DiscussionFuture directions in inhalation and respiratory drug delivery research
Friday May 29 2020
Registration and Welcome Coffee0800
0820 IRDD 2020 Chairmans Opening Address
NEW APPROACHES TO TREATING RESPIRATORY DISEASES
NEW ANALYTICAL INSIGHTS INTO DRY POWDER FORMULATIONS FOR INHALATION
0830 TBABy Masahiro Sakagami - Professor of Pharmaceutics at Virginia Commonwealth University Schoolof Pharmacy
0900 Shared Decision Making to Improve Adherence in Severe AsthmaBy Tonya Winders - President and Chief Executive Officer at Allergy amp Asthma Network
Define Severe Asthma in accord with GINA guidelines
Utilize an online interactive shared decision making tool with severe asthma patients
Outline the benefits of SDM to improve adherence
Recognize four phenotypes of severe asthma
1000 Optimising surrogate outcome measures for respiratory trialsBy Peter Robbins - Professor of Physiology at the University of Oxford
The pharmaceutical industry should engage directly in optimising surrogate outcome measures for clinical trials Medical device companies do not have the same economic incentive associated with success
Inhomogeneity in lung function is an attractive target for developing a surrogate outcome measure that is more sensitive to early disease and to therapeutic intervention than those associated with airway calibre
The current measure of inhomogeneity the lung clearance index has many failings that limit its attractive-ness as a surrogate outcome measure These failings are both conceptual and methodological
1030 Morning Coffee amp Networking Break
0930 Inhalation therapy for pulmonary arterial hypertension a pulmonary vascular diseaseBy Fakhrul Ahsan - University Distinguished Professor in the Department of Pharmaceutical Sciences at the Texas Tech University Health Sciences Center (TTUHSC)
Plain drug versus controlled released formulation
Enhanced patient compliance
Reduced systemic side effects effects and reduced frequency of administration
All Prices displayed include VAT The VAT amount will be displayed after the payment process and shown on your invoice
Name
Position
Title
Name
Position
Title
PACKAGE NAME
Address
VAT No
Company
Signature
City
Date
Postcode
Phone
Gala Dinner
This booking is invalid without signature
Please send the signed form to this contact
Diogo Lino RibeiroProject Director Europe | Porto Office
EM diogoribeiroepmgrouporg
PH +351 915 239 640
R E G I S T R A T I O N
Team Discounts 3 Delegates
10
4 Delegates
15
5+ Delegates
20
Academic Med NPO Package
Industry Package
Premium Package
Super Early BirdUntil Jan10
$1100
$1795
$3650
Early BirdUntil Feb 14
$1350
$1995
$3800
Discounted TicketUntil Apr 25
$1500
$2250
$4150
Normal TicketAfter Apr 25
$1995
$2500
$4495
The 2nd Annual IRDD Summit is an exclusive limited seat event Early bird tickets are non-refundable and subject to availability
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
PREMIUM INDUSTRY PACKAGEIndividual Registration
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
BASIC INDUSTRY PACKAGEIndividual Registration
1-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
ONE-DAY INDUSTRY PASSIndividual Registration
By sending this form I confirm that I have read and accepted the terms and conditions detailed below
ConfirmationWe will confirm your participation after receiving the signed registration form the delegate will receive the invoice within 24h of sending the signed form The hotel details will be sent 2 or 3 weeks before the start of the conferenceCancellationsCancellations made one month prior to the start of the conference will be refunded less 50 administration charge Refunds will be made after the conference Cancellations made within one month of the conference start date will receive no refund Substitutes are accepted up to 3 days before the conference Any cancellation will be accepted latest one month before the event and should be informed in written form
Force MajeureWhile every reasonable effort will be made to adhere to the advertised package EPM Group reserves the right to change event dates sites or location omit event features or merge the event with another event as it deems necessary without penalty and in such situations no refunds part refunds or alternative offers shall be made (including but not limited to any force majeure occurence) and provided that the event is not postponed to a later date nor is it merged with another event the client shall receive a credit note for the amount that the client has paid to such permanently canceled event No refunds part refunds or alternative offers shall be madeCopyrightAll Intellectual Property rights in all materials produced or distributed by EPM Group in connection with this event are expressly reserved and any unauthorized duplication publication or distribution is prohibited
SILVER SPONSORSHIP
Opportunity to give a speech at the beginning of the conference[up to 40min]8m2 exhibition space with LCD Monitor for Video PresentationsFULL page Ad in conference programCompany Banner displayed at all the Sessions including Gala DinnerLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 5 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 5 delegates registered
Speaking slot [up to 40min]6m2 exhibition space with LCD Monitor for Video Presentationsfrac12 page Ad in conference programCompany Banner displayed at the reception desk amp Coffee breaksLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 4 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 4 delegates registered
GOLD SPONSORSHIP $18000(VAT INC) $14500(VAT INC)
SPEAKER SPONSORSHIP
Speaking slot [up to 40min]6m2 exhibition spacefrac14 page Ad in conference programCompany Banner displayed at the reception deskLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 3 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 3 delegates registered
Speaking slot [up to 40min]3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 2 delegates FREE-Admission (25 discount for extra ticket)
BRONZE SPONSORSHIP $10000(VAT INC) $6700(VAT INC)
EXHIBITION PACKAGE
Speaking slot [up to 40min]Logo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
KEYNOTE SPEECH PACKAGE $4500(VAT INC) $4500(VAT INC)
Click bellow to register as a sponsor
S P O N S O R S H I P P A C K A G E S
-dd mm yyyy
-
Yes No
NEW APPROACHES TO INHALATION PRODUCT DEVELOPMENT AND PRODUCTION
1100 TBABy Wayland Rushing - Director Scientific Affairs at Eurofins BioPharma Product Testing
1500 Development of an Integrated Digital Health Product (DigihalerTM)By Mark Milton-Edwards - Head of Product amp Health Solutions - Digital Health at Teva Pharmaceuticals
1400 TBA (Development and commercialization of inhaled therapeutic products)By Michael Castagna - Chief Executive Officer at MannKind Corporation
1600 Use of 3d printing Computational fluid dynamics and customised engineering in inhalation pre-clinical developmentBy Simon Moore - Global Lead of Inhalation Science and Engineering at Covance
Learning Objectives
Designs that been assessed using computational fluid dynamics and ex vivo evaluation
Improving animal welfare and study conduct and integrity
Applying novel 3d scanning and 3d printer
DAY 2
1130 Speaking Sponsorship Available - Have your talk here
1430 Speaking Sponsorship Available - Have your talk here
1300 Business Lunch
1530 Afternoon Coffee amp Networking Break
1630 Chairmans closing remarks amp End of the IRDD Summit 2020
1200 Panel DiscussionFuture directions in inhalation and respiratory drug delivery research
Friday May 29 2020
Registration and Welcome Coffee0800
0820 IRDD 2020 Chairmans Opening Address
NEW APPROACHES TO TREATING RESPIRATORY DISEASES
NEW ANALYTICAL INSIGHTS INTO DRY POWDER FORMULATIONS FOR INHALATION
0830 TBABy Masahiro Sakagami - Professor of Pharmaceutics at Virginia Commonwealth University Schoolof Pharmacy
0900 Shared Decision Making to Improve Adherence in Severe AsthmaBy Tonya Winders - President and Chief Executive Officer at Allergy amp Asthma Network
Define Severe Asthma in accord with GINA guidelines
Utilize an online interactive shared decision making tool with severe asthma patients
Outline the benefits of SDM to improve adherence
Recognize four phenotypes of severe asthma
1000 Optimising surrogate outcome measures for respiratory trialsBy Peter Robbins - Professor of Physiology at the University of Oxford
The pharmaceutical industry should engage directly in optimising surrogate outcome measures for clinical trials Medical device companies do not have the same economic incentive associated with success
Inhomogeneity in lung function is an attractive target for developing a surrogate outcome measure that is more sensitive to early disease and to therapeutic intervention than those associated with airway calibre
The current measure of inhomogeneity the lung clearance index has many failings that limit its attractive-ness as a surrogate outcome measure These failings are both conceptual and methodological
1030 Morning Coffee amp Networking Break
0930 Inhalation therapy for pulmonary arterial hypertension a pulmonary vascular diseaseBy Fakhrul Ahsan - University Distinguished Professor in the Department of Pharmaceutical Sciences at the Texas Tech University Health Sciences Center (TTUHSC)
Plain drug versus controlled released formulation
Enhanced patient compliance
Reduced systemic side effects effects and reduced frequency of administration
All Prices displayed include VAT The VAT amount will be displayed after the payment process and shown on your invoice
Name
Position
Title
Name
Position
Title
PACKAGE NAME
Address
VAT No
Company
Signature
City
Date
Postcode
Phone
Gala Dinner
This booking is invalid without signature
Please send the signed form to this contact
Diogo Lino RibeiroProject Director Europe | Porto Office
EM diogoribeiroepmgrouporg
PH +351 915 239 640
R E G I S T R A T I O N
Team Discounts 3 Delegates
10
4 Delegates
15
5+ Delegates
20
Academic Med NPO Package
Industry Package
Premium Package
Super Early BirdUntil Jan10
$1100
$1795
$3650
Early BirdUntil Feb 14
$1350
$1995
$3800
Discounted TicketUntil Apr 25
$1500
$2250
$4150
Normal TicketAfter Apr 25
$1995
$2500
$4495
The 2nd Annual IRDD Summit is an exclusive limited seat event Early bird tickets are non-refundable and subject to availability
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
PREMIUM INDUSTRY PACKAGEIndividual Registration
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
BASIC INDUSTRY PACKAGEIndividual Registration
1-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
ONE-DAY INDUSTRY PASSIndividual Registration
By sending this form I confirm that I have read and accepted the terms and conditions detailed below
ConfirmationWe will confirm your participation after receiving the signed registration form the delegate will receive the invoice within 24h of sending the signed form The hotel details will be sent 2 or 3 weeks before the start of the conferenceCancellationsCancellations made one month prior to the start of the conference will be refunded less 50 administration charge Refunds will be made after the conference Cancellations made within one month of the conference start date will receive no refund Substitutes are accepted up to 3 days before the conference Any cancellation will be accepted latest one month before the event and should be informed in written form
Force MajeureWhile every reasonable effort will be made to adhere to the advertised package EPM Group reserves the right to change event dates sites or location omit event features or merge the event with another event as it deems necessary without penalty and in such situations no refunds part refunds or alternative offers shall be made (including but not limited to any force majeure occurence) and provided that the event is not postponed to a later date nor is it merged with another event the client shall receive a credit note for the amount that the client has paid to such permanently canceled event No refunds part refunds or alternative offers shall be madeCopyrightAll Intellectual Property rights in all materials produced or distributed by EPM Group in connection with this event are expressly reserved and any unauthorized duplication publication or distribution is prohibited
SILVER SPONSORSHIP
Opportunity to give a speech at the beginning of the conference[up to 40min]8m2 exhibition space with LCD Monitor for Video PresentationsFULL page Ad in conference programCompany Banner displayed at all the Sessions including Gala DinnerLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 5 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 5 delegates registered
Speaking slot [up to 40min]6m2 exhibition space with LCD Monitor for Video Presentationsfrac12 page Ad in conference programCompany Banner displayed at the reception desk amp Coffee breaksLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 4 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 4 delegates registered
GOLD SPONSORSHIP $18000(VAT INC) $14500(VAT INC)
SPEAKER SPONSORSHIP
Speaking slot [up to 40min]6m2 exhibition spacefrac14 page Ad in conference programCompany Banner displayed at the reception deskLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 3 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 3 delegates registered
Speaking slot [up to 40min]3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 2 delegates FREE-Admission (25 discount for extra ticket)
BRONZE SPONSORSHIP $10000(VAT INC) $6700(VAT INC)
EXHIBITION PACKAGE
Speaking slot [up to 40min]Logo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
KEYNOTE SPEECH PACKAGE $4500(VAT INC) $4500(VAT INC)
Click bellow to register as a sponsor
S P O N S O R S H I P P A C K A G E S
-dd mm yyyy
-
Yes No
All Prices displayed include VAT The VAT amount will be displayed after the payment process and shown on your invoice
Name
Position
Title
Name
Position
Title
PACKAGE NAME
Address
VAT No
Company
Signature
City
Date
Postcode
Phone
Gala Dinner
This booking is invalid without signature
Please send the signed form to this contact
Diogo Lino RibeiroProject Director Europe | Porto Office
EM diogoribeiroepmgrouporg
PH +351 915 239 640
R E G I S T R A T I O N
Team Discounts 3 Delegates
10
4 Delegates
15
5+ Delegates
20
Academic Med NPO Package
Industry Package
Premium Package
Super Early BirdUntil Jan10
$1100
$1795
$3650
Early BirdUntil Feb 14
$1350
$1995
$3800
Discounted TicketUntil Apr 25
$1500
$2250
$4150
Normal TicketAfter Apr 25
$1995
$2500
$4495
The 2nd Annual IRDD Summit is an exclusive limited seat event Early bird tickets are non-refundable and subject to availability
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
PREMIUM INDUSTRY PACKAGEIndividual Registration
2-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
BASIC INDUSTRY PACKAGEIndividual Registration
1-Days Access
Unique One-on-One meetings
Coffee Breaks amp Lunches
Cocktail Reception
Gala Dinner
VIP Airport Pick-up Service
Accommodation at the Hotel Venue
ONE-DAY INDUSTRY PASSIndividual Registration
By sending this form I confirm that I have read and accepted the terms and conditions detailed below
ConfirmationWe will confirm your participation after receiving the signed registration form the delegate will receive the invoice within 24h of sending the signed form The hotel details will be sent 2 or 3 weeks before the start of the conferenceCancellationsCancellations made one month prior to the start of the conference will be refunded less 50 administration charge Refunds will be made after the conference Cancellations made within one month of the conference start date will receive no refund Substitutes are accepted up to 3 days before the conference Any cancellation will be accepted latest one month before the event and should be informed in written form
Force MajeureWhile every reasonable effort will be made to adhere to the advertised package EPM Group reserves the right to change event dates sites or location omit event features or merge the event with another event as it deems necessary without penalty and in such situations no refunds part refunds or alternative offers shall be made (including but not limited to any force majeure occurence) and provided that the event is not postponed to a later date nor is it merged with another event the client shall receive a credit note for the amount that the client has paid to such permanently canceled event No refunds part refunds or alternative offers shall be madeCopyrightAll Intellectual Property rights in all materials produced or distributed by EPM Group in connection with this event are expressly reserved and any unauthorized duplication publication or distribution is prohibited
SILVER SPONSORSHIP
Opportunity to give a speech at the beginning of the conference[up to 40min]8m2 exhibition space with LCD Monitor for Video PresentationsFULL page Ad in conference programCompany Banner displayed at all the Sessions including Gala DinnerLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 5 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 5 delegates registered
Speaking slot [up to 40min]6m2 exhibition space with LCD Monitor for Video Presentationsfrac12 page Ad in conference programCompany Banner displayed at the reception desk amp Coffee breaksLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 4 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 4 delegates registered
GOLD SPONSORSHIP $18000(VAT INC) $14500(VAT INC)
SPEAKER SPONSORSHIP
Speaking slot [up to 40min]6m2 exhibition spacefrac14 page Ad in conference programCompany Banner displayed at the reception deskLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 3 delegates FREE-Admission (25 discount for extra ticket)VIP Airport Pick-up Service2 nights accommodation for 3 delegates registered
Speaking slot [up to 40min]3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 2 delegates FREE-Admission (25 discount for extra ticket)
BRONZE SPONSORSHIP $10000(VAT INC) $6700(VAT INC)
EXHIBITION PACKAGE
Speaking slot [up to 40min]Logo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
3m2 exhibition spaceLogo on the conference website and main stageFlyerpromo gifts into congress bagsBranding at post-event communication activitiesAccess to all SessionsBusiness Lunches amp Gala DinnerExclusive One-on-One Meetings Up to 1 delegates FREE-Admission (25 discount for extra ticket)
KEYNOTE SPEECH PACKAGE $4500(VAT INC) $4500(VAT INC)
Click bellow to register as a sponsor
S P O N S O R S H I P P A C K A G E S
-dd mm yyyy
-
Yes No
![Chapter 1...600MHz. According to predictions, by the year 2000, chip density will exceed 1 billion transistors and clock frequency will exceed 1 GHz [LiSh97]. From the 1970s through](https://static.documents.pub/doc/80x56/5f03b67a7e708231d40a6754/chapter-1-600mhz-according-to-predictions-by-the-year-2000-chip-density-will.jpg)
![Untitled-2 []...PSU Connect Monthly Magazine0tCPSE nappenings„í PSU News IOC plans $28 billion investment by 2023-24, says trillion rupees ($27.98 billion) in five. seven years](https://static.documents.pub/doc/80x56/5ea4faed43edac2d0b6ce394/untitled-2-psu-connect-monthly-magazine0tcpse-nappeningsa-psu-news-ioc.jpg)
